Abstract
The enterovirus group, named in 1957,(72,285) brought together polioviruses, coxsackieviruses, and echoviruses, all of which inhabit the human alimentary tract. These viruses share a number of clinical, epidemiologic, and ecological characteristics as well as physical and biochemical properties.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
References
Abraham, R., Chonmaitree, T., Mccombs, J., Prabhakar, B., LO Verde, R. T., and Ogra, P. L., Rapid detection of polio-virus by reverse transcription and polymerase chain amplification: Application for differentiation between poliovirus and nonpoliovirus enteroviruses, J. Clin. Microbiol. 31: 395–399 (1993).
Advisory Committee on Immunization Practices, Poliomyelitis prevention, Morbid. Mortal. Week. Rep. 31: 22–26, 31–33 (1982).
Advisory Committee on Immunization Practices ACIP), General recommendations on immunization, Morbid. Mortal. Week. Rep. 32: 1–18 (1983).
Advisory Commit the on Immunization Practices, Adult immunization, Morbid. Mortal. Week. Rep. 33 (Suppl.): 1S - 68S (1984).
Advisory Commit the on Immunization Practices ACIP), New recommended schedule for active immunization of normal infants and children, Morbid. Mortal. Week. Rep. 34: 577–579 (1986).
Advisory Committee on Immunization Practices ACIP), Immunization of children infected with human T-lymphotropic virus type IlUlymphadenopathy-associated virus, Morbid. Mortal. Week. Rep. 35: 595–598, 603–606 (1986).
Advisory Committee on Immunization Practices ACIP), Poliomyelitis prevention: Enhanced-potency inactivated poliomyelitis vaccine-Supplementary statement, Morbid. Mortal. Week Rep. 36: 795–798 (1987).
Agol, V. I., Drozdov, S. G., Frolova, M. P, Grachev, V. R, Kolesnikova, M. S., Kozlov, V. G., Ralph, N. M., Romanova, L. I., Tolskaya, E. A., and Viktorova, E. G., Neurovirulence of the intertypic poliovirus recombinant v3/a1–25: Characterization of strains isolated from the spinal cord of diseased monkeys and evaluation of the contribution of the 3’ half of the genome, J. Gen. Vital. 66: 309–316 (1985).
Agol, V. I., Drozdov, S. G., Grachev, V. R, Kolesnikova, M. S., Kozlov, V. G., Ralph, N. M., Romanova, L. I., Tolskaya, E. A., Tyufanov, A. V., and Viktorova, E. G., Recombinants between attenuated and virulent strains of poliovirus type 1: Derivation and characterization of recombinants with centrally located crossover points, Virology 143: 467–477 (1985).
Alexander, J. P, Baden, L., Pallansch, M. A., and Anderson, L. J., Enterovirus 71 infections and neurologic disease, United States, 1977–1991, J. Infect. Dis. 169: 905–908 (1994).
Alexander, J. R, JR., Chapman, L. E., Pallansch, M. A., Stephenson, W. T., Torok, T. J., and Anderson, L. J., Coxsackievirus B2 infection and aseptic meningitis: A focal outbreak among members of a high school football team, J. Infect. Diseases 167: 1201–1205 (1993).
Andrew, C. G., Drachman, D. B., Pestronk, A., and Narayan, O., Susceptibility of skeletal muscle to Coxsackie AZ virus infection: Effects of botulinum toxin and denervation, Science 223: 714–716 (1984).
Andrus, J. K., DE Quadros, C., Olive, J.-M., and Hull, H. F., Screening of cases of zcute flaccid paralysis for poliomyelitis eradication: Ways to improve specificity, Bull. WHO 70: 591–596 (1992).
Assaad, E, and Cockburn, W. C., Four-year study of WHO virus reports on enteroviruses other than poliovirus, Bull. WHO 46: 329–336 (1972).
Atmar, R. L., and Georghiou, R. R., Classification of respiratory tract picornavirus isolates as enteroviruses or rhinoviruses by using reverse transcription-polymerase chain reaction, J. Clin. Microbiol. 31: 2455–2546 (1993).
Baltimore, D., Picomaviruses are no longer black boxes, Science 229: 1366–1367 (1985).
Banatvala, J. E. (Ed.), Viral Infections of the Heart, Edward Arnold, London, 1993.
Bantvala, J. E., Schernthaner, G., Schober, E., DE Silva, L. M., Bryant, J., Borkenstein, M., Brown, D., Menser, M. A., and Silink, M., Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia, Lancet 1: 1409–1412 (1985).
Banker, D. D., and Melnick, J. L., Isolation of Coxsackie virus (C virus) from North Alaskan Eskimos, Am. J. Hyg. 54: 383–390 (1951).
Barrettconnor, E., Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence, Rev. Infect. Dis. 7: 207–215 (1985).
Benton, W. H., and Ward, R. L., Induction of cytopathogenicity in mammalian cell lines challenged with culturable enteric viruses and its enhancement by 5-iododeoxyuridine, Appl. Environ. Microbiol. 43: 861–868 (1982).
Benyesh-Melnick, M., Melnick, J. L., Rawls, W. E., Wimberly, I., Barrera-Oro, J., Ben-Porath, E., and Rennick, V., Studies of the immunogenicity, communicability, and genetic stability of oral poliovaccine administered during the winter, Am. J. Epidemiol. 86: 112–136 (1967).
Berg, G. (ED.), Transmission of Viruses by the Water Route, John Wiley & Sons, New York, 1967.
Berg, G., Bodily, H., Lennette, E. H., Melnick, J. L., and Metcalf, T. G. (Eds.), Viruses in Water, American Public Health Association, Washington, 1976.
Bergelson, J. M., Shepley, M. P., Chan, B. M. C., Hemler, M. E., and Finberg, R. W., Identification of the integrin Vla-2 as a receptor for echovirus 1, Science 255: 1718–1720 (1992).
Berlin, L. E., Rorabaugh, M. L., Heldrich, F., Roberts, K., Doran, T., and Modlin, J. E, Aseptic meningitis in infants 2 years of age: Diagnosis and etiology, J. Infect. Dis. 168: 888–892 (1993).
Bernier, R. H., Prevalence survey techniques for paralytic polio: An update. Expanded Programme on Immunization Working Paper Epugag 83/10, World Health Organization, Geneva, 1983.
Bukerk, H., Poliomyelitis in the Netherlands, in: International Symposium on Reassessment of Inactivated Poliomyelitis Vaccine, Developments in Biological Standardization, Vol. 47, pp. 233–240, S. Karger, Basel, 1981.
Blackburn, R. V., Racaniello, V. R., and Richthand, V. F., Construction of an infectious cDNA clone of echovirus 6, Virus Res. 22: 71–78 (1991).
Blattner, R. J., Williamson, A. R, and Heys, F. M., Role of viruses in the etiology of congenital malformations, Prog. Med. Virol. 15: 1–41 (1973).
Blomberg, J., Lycke, E., Ahlfors, K., Johnsson, T., Wolontis, S., and Von Zeipel, G., New enterovirus type associated with epidemic of aseptic meningitis and/or hand, foot, and mouth diease, Lancet 2: 112 (1947).
Bloom, H. H., Mack, W. N., Krueger, B. J., and Mallmann, W. L., Identification of enteroviruses in sewage, J. Infect. Dis. 105: 61–68 (1959).
Bodian, D., Poliomyelitis: Pathogenesis and histopathology, in: Viral and Rickettsial Infections of Man, 3rd ed. (T. M. Rivers and E L. Horsfall, JR., Eds.), pp. 479–518, J. B. Lippincott, Philadelphia, 1959.
Bodian, D., and Horstmann, D. M., Polioviruses, in: Viral and Rickettsial Infections of Man, 4th ed. (F. L. Horsfall, JR., and I. Tamm, Eds.), pp. 430–473, J. B. Lippincott, Philadelphia, 1965.
Bodan, J., Nilsson, B., and Juto, P., Serum IgA, IgG, and IgM responses to different enteroviruses as measured by a coxsackie B5-based indirect Elisa, J. Med. Virol. 38: 32–35 (1992).
Brown, F., and Lewis, B. P., Poliovirus attenuation: Molecular mechanisms and practical aspects, Dev. Biol. Stand. 78: 1–187 (1993).
Brown, F., Talbot, R, and Burrows, R., Antigenic differences between isolates of swine vesicular disease virus and their relationship to Coxsackie B5 virus, Nature 245: 315–316 (1973).
Brown, F., and Wild, F., Variation in the coxsackievirus type B5 and its possible role in the etiology of swine vesicular disease, Intervirology 3: 125–128 (1974).
Brown, G. C., and Karunas, R. S., Relationship of congenital anomalies and maternal infection with selected enteroviruses, Am. J. Epidemiol. 95: 207–217 (1972).
Brown, G. C., and O’Leary, T. P., Fluorescent antibody responses of cases and contacts of hand, foot, and mouth disease, Infect. Immun. 9: 1098–1101 (1974).
Bruce, D., AL-Nakib, W., Forsyth, M., Stanway, G., and Almond, J. W., Detection of enterovirus using cDNA and synthetic oligonucleotide probes, J. Virol. Methods 25: 223–240 (1989).
Burch, G. E., Shewey, L. L., and Harb, T. M., Coxsackie B4 viruses and atrial myxoma, Am. Heart J. 88: 634–639 (1974).
Burch, G. E., Sun, S. C., Chu, K. C., Sohal, R. S., and Colcolough, H. L., Interstitial and coxsackievirus B myocarditis in infants and children: A comparative histologic and immunofluorescent study of 50 autopsied hearts, J.A.M.A. 203: 1–8 (1968).
Butterworth, B. E., A comparison of the virus-specific polypeptides of encephalomyocarditis virus, human rhinovirus-1A, and poliovirus, Virology 56: 439–453 (1973).
Carstens, J. M., Tracy, S., Chapman, N. M., and Gauntt, C. J., Detection of enteroviruses in cell cultures by using in situ transcription, J. Clin. Microbiol. 30: 25–35 (1992).
Caverly, C. S., Notes of an epidemic of acute anterior poliomyelitis, J.A.M.A. 26: 1–5 (1896).
Cello, J., Samuelson, A., Stalhandske, P., Svennerholm, T., Jeansson, S., and Forsgren, M., Identification of group-common linear epitopes in structural and nonstructural proteins of enteroviruses by using synthetic peptides, J. Clin. Microbiol. 31: 911–916 (1992).
Center For Disease Control, Poliomyelitis Surveillance Summary 1974–76 (1977).
Center For Disease Control, Poliomyelitis-Pennsylvania, Maryland, Morbid. Mortal. Week. Rep. 28: 49–50 (1979).
Centers For Disease Control, Poliomyelitis Surveillance Summary 1977–78 (1980).
Centers For Disease Control, Enterovirus surveillance-United States, 1984, Morbid. Mortal. Week. Rep. 33: 388 (1984).
Centers For Disease Control, Enterovirus surveillance-United States, 1985, Morbid Mortal. Week. Rep. 34: 494–495 (1985).
Centers For Disease Control, Annual Summary 1984, Morbid. Mortal. Week Rep. 33: 46–47 (1986).
Centers For Disease Control, Poliomyelitis, Morbid. Mortal. Week. Rep. 35: 180–182 (1986).
Centers For Disease Control, Preliminary report: Paralytic poliomyelitis-Senegal, 1986, Morbid. Mortal. Week. Rep. 36: 387–390 (1987).
Centers For Disease Control, Aseptic meningitis-New York State and United States, Weeks 1–36,1991, Morbid. Mortal. Week. Rep. 40: 773–775 (1991).
Centers For Disease Control, Update: Poliomyelitis outbreak-Netherlands, Morbid. Mortal. Week. Rep. 41: 917–919 (1992).
Chang, W. K., Liu, K. C., Foo, T. C., Lam, M. W., and Chan, C. F., Acute haemorrhagic conjunctivitis in Hong Kong 1971–1975, Southeast Asian J. Trop. Med. Public Health 8: 1–6 (1977).
Chapman, N. M., Tracy, S., Gauntt, C. J., and Fortmueller, U., Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization, J. Clin. Microbiol. 28: 843–850 (1990).
Chatterjee, S., Quarcoopome, C. O., and Apenteng, A., Unusual type of epidemic of conjunctivitis in Ghana, Br. J. Ophthalmol. 54: 628–630 (1970).
Cherry, J. D., Nonpolio enteroviruses: Coxsackieviruses, echo-viruses and enteroviruses, in: Textbook of Pediatric Infectious Diseases, (R. D. Feigin and J. D. Cherry, Eds.), pp. 1316–1365, W. B. Saunders, Philadelphia, 1981.
Cherry, J. D., Enteroviruses, in: Textbook of Pediatric Infectious Diseases, 3rd ed. (R. D. Feigin and J. D. Cherry, Eds.), pp. 1705–1753, W. B. Saunders, Philadelphia, 1992.
Chonmaitree, T., Menegus, M. A., Schervish-Swierkosz, E. M., and Schwalenstocker, E., Enterovirus 71 infection: Report of an outbreak with two cases of paralysis and a review of the literature, Pediatrics 67: 489–493 (1981).
Chumakov, M. R, Voroshilova, M. K., Shindarov, L., Lavrova, I., Gracheva, L., Koroleva, G., Vasilenko, S., Bradvarova, I., Nikolova, M., Gyurova, S., Gacheva, M., Mrrov, G., Ninov, M., Tsylka, E., Robinson, I., Frolova, M., Bashkirtsev, V., Martjanova, L., and Rodin, V. I., Enterovirus 71 isolated from cases of poliomyelitis-like disease in Bulgaria, Arch. Virol. 60: 329–340 (1979).
Clarke, N. A., and Kabler, R. W., Human enteric viruses in sewage, Health Lab. Sci. 1: 44–49 (1964).
Cockburn, W. C., The work of the WHO Consultative Group in Poliomyelitis Vaccines, Bull. WHO 66: 143–154 (1988).
Cockburn, W. C., and Drozdov, S. G., Poliomyelitis in the world, Bull. WHO 42: 405–417 (1970).
Cole, C. N., Defective interfering (DI) particles of poliovirus, Prog. Med. Virol. 20: 180–207 (1975).
Coleman, T. J., Gamble, D. R., and Taylor, K. W., Diabetes in mice after Coxsackie B4 infection, Br. Med. J. 3: 25–27 (1973).
Collingham, K. E., Pollock, T. M., and Roebuck, M. O., Paralytic poliomyelitis in England and Wales, 1976–77, Lancet 1: 976–977 (1978).
Committee ON The Echo Viruses, Enteric cytopathogenic human orphan (ECHO) viruses, Science 122: 1187–1188 (1955).
Committee ON The Enteroviruses, National Foundation for Infantile Paralysis: The enteroviruses, Am. J. Public Health 47: 1556–1566 (1957).
Cooney, M. K., Hall, C. E., and Fox, J. P., The Seattle Virus Watch. M. Evaluation of isolation methods and summary of infections detected by virus isolations, Am. J. Epidemiol. 96: 286–305 (1972).
Cooper, P. D., Agol, V. I., Bachrach, H. L., Brown, F., Ghendon, Y., Gibbs, A. J., Gillespie, J. H., Lonberg-Holm, K., Mandel, B., Melnick, J. L., Mohanty, S. B., Povey, R. C., Rueckert, R. R., Schah-ER, F. L., and Tyrrell, D. A. J., Picomaviridae: Second report, Intervirology 10: 165–180 (1978).
Couch, R. B., Douglas, R. G., JR., Lindgren, K. M., Gerone, P. J., and Knight, V., Airborne transmission of respiratory infection with coxsackievirus A type 21, Am. J. Epidemiol. 91: 78–86 (1978).
Craighead, J. E., The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus, Prog. Med. Virol. 19: 161–214 (1975).
Crowell, R. L., and Goldberg, B., Propagation and assay of group A coxsackieviruses in RD cells, Abstr. Ann. Meeting Am. Soc. Microbiol. 44: 208 (1974).
Curnen, E. C., Shaw, E. W., and Melnick, J. L., Disease resembling nonparalytic poliomyelitis associated with a virus pathogenic for infant mice, J.A.M.A. 141: 894–901 (1949).
Dagan, R., and Menegus, M. A., A combination of four cell types for rapid detection of enteroviruses in clinical specimens, J. Med. Virol. 19: 219–228 (1986).
Dahling, D. R., Berg, G., and Berman, D., BGM, a continuous cell line more sensitive than primary rhesus and African green monkey kidney cells for the recovery of viruses from water, Health Lab. Sci. 11: 275–282 (1974).
Dales, L., Poliovaccine strategy, Lancet 1: 286 (1985).
Dalldorf, G., Neuropathogenicity of group A Coxsackie viruses, J. Exp. Med. 106: 69–76 (1957).
Dalldorf, G., and Melnick, J. L., Coxsackieviruses, in: Viral and Rickettsial Infections of Man, 4th ed. (F. L. Horsfall, JR., and I. Tamm, Eds.), pp. 474–512, J. B. Lippincott, Philadelphia, 1965.
Dalldorf, G., Sickles, G. M., Plager, H., and Gifford, R., A virus recovered from the feces of “poliomyelitis” patients pathogenic for suckling mice, J. Exp. Med. 89: 567–582 (1949).
Davies, D. E, Hughes, C. A., Macvicar, J., Hawkes, P., and Mair, H. J., Echovirus-11 infection in a special-care baby unit, Lancet 1: 96 (1979).
Davis, L. E., Bodian, D., Price, D., Butler, I. J., and Vickers, J. H., Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child, N. Engl. J. Med. 297: 241–245 (1977).
DE Quadros, C. A., Andrus, J. K., Olive, J.-M., and Demacedo, C. G., Polio eradication from the Western Hemisphere, Annu. Rev. Publ. Health 13: 239–252 (1992).
Desselberger, U., and Flewett, T. H., Clinical and public health virology: A continuous task of changing pattern, Prog. Med. Virol. 40: 48–81 (1993).
Diesel, R., Gross, L. L., and Collins, D. N., Isolation of a new enterovirus, Proc. Soc. Exp. Biol. Med 148: 203–207 (1975).
Domok, I., Balayan, M. S., Fayinka, O. A., Skrtic, N., Sone I, A. D., and Harland, P. S. E. G., Factors affecting the efficacy of live poliovirus vaccines in warm climates, Bull. WHO 51: 333–347 (1974).
Dong, D.-X., Immunization with oral poliovirus vaccine in China, Prog. Med. Virol. 31: 212–221 (1985).
Dorries, R., and Ter Meulen, V., Specificity of lgM antibodies in acute human coxsackievirus B infections, analysed by indirect solid phase enzyme immunoassay and immunoblot technique, J. Gen. Virol. 64: 159–167 (1983).
Dreesman, G. R., Sanchez, Y., Ionescu-Matiu, I., Sparrow, J. T., Six, H. R., Peterson, D. L., Hollinger, F. B., and Melnick, J. L., Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides, Nature 295: 158–160 (1982).
Duxcan, I. B. R., A comparative study of 63 strains of echovirus type 30, Arch. Virusforsch. 25: 93–104 (1968).
Editorial, Neurovirulence of enterovirus 70, Lancet 1: 373–374 (1982).
Editorial, Polio reconsidered, Lancet 2: 1309–1310 (1984).
Editorial, Expanded immunisation, Lancet 1: 438–439 (1985).
Editorial, Late sequelae of polio, Lancet 2: 1195–1196 (1986).
Eggers, H. J., Mertens, T., and Gruneklee, D., Coxsackie infection and diabetes, Lancet 2: 631 (1983).
El-Hagrassy, M. M. O., Banatvala, J. E., and Coltart, D. J., Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases, Lancet 2: 1160 (1980).
Emini, E. A., Jameson, B. A., and Wimmer, E., Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides, Nature 304: 699–703 (1983).
Enders, J. F., Weller, T. H., and Robbins, F. C., Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues, Science 109: 85–87 (1949).
Enders, J. F., Weller, T. H., and Robbins, F. C., Alteration in pathogenicity for monkeys of Brunhilde strain of poliomyelitis virus following cultivation in human tissues, Fed. Proc. 11: 467 (1952).
Evans, A. S., Criteria for control of infectious diseases with poliomyelitis as an example, Prog. Med. Virol. 29: 141–165 (1984).
Faulk, W. P., Vyas, G. N., Phillips, C. A., Fudenberg, H. H., and Chism, K., Passive hemagglutination test for antirhinovirus antibodies, Nature (New Biol.) 231: 101–104 (1971).
Ferguson, M., Evans, D. M. A., Magrath, D. I., Minor, P. D., Almond, J. W., and Schild, G. C., Induction by synthetic peptides of broadly reactive, type-specific neutralizing antibody to poliovirus type 3, Virology 142: 505–515 (1985).
Fernandez DE Castro, P. J., [Comments on the geographic distribution of poliomyelitis in the Americas: Notes for a program on continental eradication of poliomyelitis], Rev. Salud Pub. Mexico 26:Issue #3 (1984).
Fernandez-Tomas, C. B., and Baltimore, D., Morphogenesis of poliovirus. II. Demonstration of a new intermediate, the pro-virion, J. Virol. 12: 1122–1130 (1973).
Foster, S. O., Kessengmaben, G., N’Jie, H., and Coffi, E., Control of poliomyelitis in Africa, Rev. Infect. Dis. 6: (Suppl. 2): S433–5437 (1984).
Fox, J. P., Epidemiological aspects of coxsackie and echo virus infections in tropical areas, in: Proceedings 7th International Congresses on Tropical Medicine and Malaria, Vol. 3, pp. 212–213, International Congress on Tropical Medicine and Malaria, Rio de Janeiro, 1964.
Fox, J. P., Family-based epidemiologic studies: The second Wade Hampton Frost Lecture, Am. J. Epidemiol. 99: 165–179 (1974).
Fox, J., Eradication of poliomyelitis in the United States: A commentary on the Salk reviews, Rev. Infect. Dis. 2: 277–281 (1980).
Fox, J. P., Modes of action of poliovirus vaccines and relation to resulting immunity, Rev. Infect. Dis. 6 (Suppl. 2): S352 - S355 (1984).
Fox, J. E, Hall, C. E., Cooney, M. K., Luce, R. E., and Kronmal, R. A., The Seattle Virus Watch. II. Objectives, study population and its observation, data processing and summary of illnesses, Am. J. Epidemiol. 96: 270–285 (1972).
Foerschle, J. E., Feorino, P. M., and Gelfand, H. J. M., A continuing surveillance of enterovirus infection in healthy children in six United States cities. II. Surveillance enterovirus isolates 1960–1963 and comparison with enterovirus isolates from cases of acute central nervous system disease, Am. J. Epidemiol. 83: 455–469 (1966).
Fuchs, F., Leparc, I., Kopecka, H., Garin, D., and Aymard, M., Use of cRNA digoxigenin-labelled probes for detection of enteroviruses in humans and in the environment, J. Virol. Methods 42: 217–226 (1993).
Furesz, J., Armstrong, R. E., and Contreras, G., Viral and epidemiological links between poliomyelitis outbreaks in unprotected communities in Canada and the Netherlands, Lancet 2: 1248 (1978).
Furesz, J., and Contreras, G., Poliomyelitis in Finland, Lancet 2: 693 (1986).
Gamble, D. R., Taylor, K. W., and Cumming, H., Coxsackie viruses and diabetes mellitus, Br. Med. J. 4: 260–262 (1973).
Gauntt, C. J., Gomez, P. T., Dufi EY, P. S., Grant, J. A., Trent, D. W., Witherspoon, S. M., and Paque, R. E., Characterization and myocarditis capabilities of coxsackievirus B3 variants in selected mouse strains, J. Virol. 52: 598–605 (1984).
Gauntt, C. J., Gudvangen, R. J., Brans, Y. W., and Marlin, A. E., Coxsackievirus group B antibodies in the ventricular fluid of infants with severe anatomic defects of the central nervous system, Pediatrics 76: 64–68 (1985).
Gauntt, C. J., Jones, D. C., Huntington, H. W., Arizpe, H. M., Gudvangen, R. J., and Deshambo, R. M., Murine forebrain anomalies induced by coxsackievirus B3 variants, J. Med. Virol. 14: 341–355 (1984).
Gear, J. H. S., Nonpolio causes of polio-like paralytic syndromes, Rev. Infect. Dis. 6 (Suppl. 2): S379 - S385 (1984).
Gear, J. H. S., and Measroch, V., Coxsackievirus infections of the newborn, Prog. Med. Virol. 15: 42–62 (1973).
Gelfand, H. M., Fox, J. P., and Leblanc, D. R., The enteric viral flora of a population of normal children in southern Louisiana, Am. J. Trop. Med. 6: 521–531 (1957).
Gelfand, H. M., Holguin, A. H., Marchetti, G. F., and Feorino, P. M., A continuing surveillance of enterovirus infections in healthy children in six United States cities. I. Viruses isolated during 1960 and 1961, Am. J. Hyg. 78: 358–375 (1963).
Gibson, J. P., and Righthand, V. F., Persistence of echovirus 6 in cloned human cells, J. Virol. 54: 219–223 (1985).
Gilbert, G. L., Dickson, K. E., Waters, M. J., Kennett, M. L., Land, S. A., and Sneddon, M., Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement, Pediatr. Infect. Dis. 7: 484–488 (1988).
Glimaker, M., Abebe, A., Johansson, B., Ehrnst, A., Olcen, P, and Strannegard, O., Detection of enteroviral RNA by polymerase chain reaction in faecal samples from patients with aseptic meningitis, J. Med. Virol. 38: 54–61 (1992).
Godman, G. C., Bunting, H., and Melnick, J. L., The histopathology of Coxsackie virus infection in mice. I. Morphologic observations with four different viral types, Am. J. Pathol. 28: 223–257 (1952).
Goldblum, N., Swartz, T., Gerichter, C. B., Handsher, R., Lasch, E. E., and Melnick, J. L., The natural history of poliomyelitis in Israel, 1949–1982, Prog. Med. Virol. 29: 115–123 (1984).
Goldfield, M. S., Srihongse, S., and Fox, J. E, Hemagglutinins associated with certain human enteric viruses, Proc. Soc. Exp. Biol. Med. 96: 788–791 (1957).
Graham, S., Wang, E. C. Y., Jenkins, O., and Borysiewicz, L. K., Analysis of the human T-cell response to picornaviruses: Identification of T-cell epitopes close to B-cell epitopes in polio-virus, J. Virol. 67: 1627–1637 (1993).
Graves, J. H., Serological relationship of swine vesicular disease virus and coxsackie B5 virus, Nature 245: 314–315 (1973).
Green, M. S., Handsher, R., Cohen, D., Melnick, J. L., Slepon, R. S., Mendelsohn, E., and Danon, Y. L., Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel: Evidence supporting the need for a booster immunization in adolescents, Vaccine 11: 75–81 (1993).
Gregg, M. B., Paralytic poliomyelitis can be eliminated, Rev. Infect. Dis. 6 (Suppl. 2): S577 - S580 (1984).
Grinstein, S., Melnick, J. L., and Wallis, C., Virus isolations from sewage and from a stream receiving effluents of sewage treatment plants, Bull. WHO 42: 291–296 (1970).
Grist, N. R., Poliovaccine strategy, Lancet 1: 286 (1985).
Grist, N. R., and Bell, E. J., Enteroviral etiology of the paralytic poliomyelitis syndrome. Studies before and after vaccination, Arch. Environ. Health 21: 382–387 (1970).
Grist, N. R., and Bell, E. J., Paralytic poliomyelitis and non-polio enteroviruses: Studies in Scotland, Rev. Infect. Dis. 6 (Suppl. 2): S385 - S386 (1984).
Grist, N. R., Bell, E. J., and Assaad, F., Enteroviruses in human disease, Prog. Med. Virol. 24: 114–157 (1978).
Grist, N. R., Bell, E. J., and Reid, E., The epidemiology of enteroviruses, Scottish Med. J. 20: 27–31 (1975).
Gyorkey, E, Cabral, G. A., Gyorkey, P. K., Uribe-Botero, G., Dreesman, G. R., and Melnick, J. L., Coxsackievirus aggregates in muscle cells of a polymyositis patient, Intervirology 10: 69–77 (1978).
Hagiwara, A., Tagaya, I., and Yoneyama, T., Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection, Intervirology 9: 60–63 (1978).
Hall, C. E., Cooney, M. K., and Fox, J. P., The Seattle Virus Watch Program. I. Infection and illness experience of Virus Watch families during a community-wide epidemic of echovirus type 30 aseptic meningitis, Am. J. Public Health 60: 1456–1465 (1970).
Hallam, N. F., Eglin, R. P., Holland, P, Bell, E. J., and Squier, M. V., Fatal coxsackie B meningoencephalitis diagnosed by serology and in-situ nucleic acid hybridisation, Lancet 2: 1213–1214 (1986).
Halsey, N., and Galazka, A., The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age, Bull. WHO 63: 1151–1169 (1985).
Hammon, W. MD., Coriell, L L, and Wehrle, P. F., Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnosis, J.A.M.A. 51: 1272–1285 (1953).
Hammon, W., McD., Ludwig, E. H., Sather, G., and Yohn, D. S., Comparative studies on patterns of family infections with polioviruses and ECHO virus type 1 on an American military base in the Philippines, Am. J. Public Health 47: 802–811 (1957).
Hampil, B., Melnick, J. L., Wallis, C., Brown, R. W., Braye, E. T., and Adams, R. R., JR., Preparation of antiserum to enteroviruses in large animals, J. Immunol. 95: 895–908 (1965).
Hannington, G., Booth, J. C., BowEs, R. J., and Stern, H., Coxsackie B virus-specific IgM antibody and myocardial infarction, J. Med. Microbiol. 21: 287–291 (1986).
Harris, L. F., Haynes, R. E., Cramblett, H. G., Conant, R. M., ANo Jenkins, G. R., Antigenic analysis of echoviruses 1 and 8, J. Infect. Dis. 127: 63–68 (1973).
Harris, T. J. R., and Brown, E, Correlation of polypeptide composition with antigenic variation in the swine vesicular disease and coxsackie B5 viruses, Nature 258: 758–760 (1975).
Harrison, S. C., Common cold virus and its receptor, Proc. Natl. Acad. Sci. USA 90: 783 (1993).
Hartig, P. C., Madge, G. E., and Webb, S. R., Diversity within a human isolate of Coxsackie B4: Relationship to viral-induced diabetes, J. Med. Virol. 12: 23–30 (1983).
Hasegawa, A., and Inouye, S., Production in guinea pigs of antibodies to cross-reactive antigenic determinants of human enteroviruses, J. Clin. Microbiol. 17: 458–462 (1983).
Hawley, H. B., Morin, D. P., Geraghty, M. E., ToMkow, J., and Phillips, C. A., Coxsackievirus B epidemic at a boy’s summer camp: Isolation of virus from swimming water, J.A.M.A. 226: 33–36 (1973).
Health and Welfare Canada, Wild poliovirus isolated in Alberta, 1993, Can. Commun. Dis. Rep. 19: 57–58 (1993).
Henderson, R. H., and Sundaresan, T., Cluster sampling to assess immunization coverage: A review of experience with a simplified sampling methodology, Bull. WHO 60: 253–260 (1982).
Hennessen, W., and Van Wftfl, A L (Eds.), Reassessment of Inactivated Poliomyelitis Vaccine: Developments in Biological Standardization, Vol. 47, S. Karger, Basel, 1981.
Heymann, D. L., Floyd, V. D., Luchnevski, M., Kessengmaben, G., and Mvongo, F., Estimation of incidence of poliomyelitis by three survey methods in different regions of the United Republic of Cameroon, Bull. WHO 61: 501–507 (1983).
Hierholzer, J. C., Bingham, P. G., Coombs, R. A., Stone, Y. O., and Hatch, M. H., Quantitation of enterovirus-70 antibody by microneutralization test and comparison with standard neutralization, hemagglutination-inhibition, and complement-fixation tests with different virus strains, J. Clin. Microbiol. 19: 826–830 (1984).
Hierholzer, J. C., Hilliard, K. A., and Esposito, J. J., Serosurvey for “acute hemorrhagic conjunctivitis” virus (enterovirus 70) antibodies in the southeastern Untied States, with review of the literature and some epidemiologic implications, Am. J. Epidemiol. 102: 533–544 (1975).
Hodes, D. S., and Espinoza, D. V., Temperature sensitivity of isolates of echovirus type 11 causing chronic meningoencephalitis in an agammaglobulinemic patient, J. Infect. Dis. 144: 377 (1981).
Holle, J. M., Chow, M., and Filman, D. J., Three-dimensional structure of poliovirus at 2.9 A resolution, Science 229: 1358–1365 (1985).
Hollinger, E. B., Andre, E, and Melnick, J. L. (Eds.), International Symposium on Active Immunization against Hepatitis A, Vaccine 10(Suppl. l):1–174 (1992).
Honig, E. I., Melnick, J. L., IsAcsoN, P., Parr, R., Myers, I. L., and Walton, M., An epidemiological study of enteric virus infections: Poliomyelitis, Coxsackie, and orphan (ECHO) viruses isolated from normal children in two socioeconomic groups, J. Exp. Med. 103: 247–262 (1956).
Horstmann, D. M., Control of poliomyelitis: A continuing paradox, J. Infect. Dis. 146: 540–551 (1982).
Horstmann, D. M., Emmons, J., Gimpel, L., Subrahmanyan, T., and Riordan, J. T., Enteroviruses surveillance following a community-wide oral poliovirus vaccination program: A seven-year study, Am. J. Epidemiol. 97: 173–186 (1973).
Horstmann, D. M., Mccollum, R. W., and Mascola, A. D., Viremia in human poliomyelitis, J. Exp. Med. 99: 355–369 (1954).
Hoyt, T., Remaining problems before eradication of poliomyelitis can be accomplished, Prog. Med. Virol. 38: 42–55 (1991).
Hoyt, T., and Roivainen, M., Peptide antisera targeted to a conserved sequence in poliovirus capsid protein VP1 cross-react widely with members of the genus Enterovirus, J. Clin. Microbiol. 31: 1083–1087 (1993).
Hovt, T., Huovilainen, A., Kuronen, T., Poyry, T., Salama, N., Cantell, K., Kinnunen, E., Lapinleimu, K., Roivainen, M., Stenvik, M. Silander, A., Thoden, C.-J., Salminen, S., and Weckstrom, P., Outbreak of paralytic poliomyelitis in Finland: Widespread circulation of antigenically altered polio-virus type 3 in a vaccinated population, Lancet 1: 1427–1432 (1986).
Hsiung, G. D., and Melnick, J. L., Morphologic characteristics of plaques produced on monkey kidney monolayer cultures by enteric viruses (poliomyelitis, Coxsackie and ECHO groups), J. Immunol. 78: 128–136 (1957).
Huber, S. A., Haisch, C., and Lodge, P. A., Coxsackievirusinduced myocarditis: Model for picornavirus-induced auto-immunity, Semin. Virol. 1: 289–295 (1990).
Hughes, P. J., Evans, D. M. A., Minor, P. D., Schild, G. C., Almond, J. W., and Stanway, G., The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland, J. Gen. Virol. 67: 2093–2102 (1986).
Humphrey, D. D., Kew, O. M., and Feorino, P. M., Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses, Infect. Immun. 36: 841–843 (1982).
Hyypia, T., Stalhandske, P., Vainionpaa, R., and Pettersson, U., Detection of enteroviruses by spot hybridization, J. Clin. Microbiol. 19: 436–438 (1984).
International Poliomyelitis Conferences, Poliomyelitis: Papers and Discussions Presented at the First through Fifth International Poliomyelitis Conferences,(M. Fishbein, Ed.), J. B. Lippincott, Philadelphia, 1949, 1952, 1955, 1958, 1961.
International Symposium ON Poliomyelitis Control, Pan American Health Organization, Washington, Rev. Infect. Dis. 6 (Suppl. 2): S301 - S601 (1984).
Ishiko, H., Takeda, N., Miyamura, K., Kato, N., Tanimura, M., Lin, K. H., Yin-Murphy, M., Tam, J. S., Mu, G. F., and Yamazaki, S., Phylogenetic analysis of a coxsackievirus A24 variant: The most recent worldwide pandemic was caused by progenies of a virus prevalent around 1981, Virology 187: 748–759 (1992).
Itoh, H., and Melnick, J. L., The infection of chimpanzees with ECHO viruses, J. Exp. Med. 106: 677–688 (1957).
Itoh, H., and Melnick, J. L., Double infections of single cells with ECHO 7 and Coxsackie A9 viruses, J. Exp. Med. 109: 393–406 (1959).
Jackson, G. G., and Muldoon, R. L., Viruses causing common respiratory infections in man, J. Infect. Dis. 127: 328–408 (1973).
Jacobson, M. F., Asso, J., and Baltimore, D., Further evidence on the formation of poliovirus proteins, J. Mol. Biol. 49: 657–669 (1970).
Janda, Z., Adam, E., and Vonka, V., Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus, Arch. Virusforsch. 20: 87–98 (1967).
Jenista, J. A., Powell, K. R., and Menegus, M. A., The epidemiology of neonatal enterovirus infection, J. Pediatrics 104: 685–690 (1984).
John, T. J., Christopher, S., and Abraham, J., Neurological manifestation of acute haemorrhagic conjunctivitis due to enterovirus 70, Lancet 2: 1283–1284 (1981).
Jowls, R. B., FAuNswoRth, S., Thompson, H., and Brady, F., Two voluntary mass immunization programs using Sabin oral vaccine, J.A.M.A. 183: 171–175 (1963).
Johnson, I., Hammond, G. W., and Verma, M. R, Nosocomial coxsackie B4 virus infections in two chronic-care pediatric neurological wards, J. Infect. Dis. 151: 1153–1156 (1985).
Johnston, R. T., Late progression of poliomyelitis paralysis: Discussion of pathogenesis, Ref Infect. Dis. 6 (Suppl. 2): S568 - S570 (1984).
Johnstone, T., Poliovaccine strategy, Lancet 2: 695 (1985).
Kajigaya, S., Arakawa, H., Kuge, S., Kos, T., Imura, N., and Nomoto, A., Isolation and characterization of defective-interfering particles of poliovirus Sabin I strain, Virology 142: 307–316 (1985).
Kandolf, R., and Hofschneider, P. H., Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: Full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells, Proc. Natl. Acad. Sci. USA 82: 4818–4822 (1985).
Kandolf, R., Klingel, K., Znri, R, Selinka, H.-C., Raab, U., Schneiderbrachert, W., and Bultmann, B., Molecular pathogenesis of enterovirus-induced myocarditis: Virus persistence and chronic inflammation, Intervirology 35: 140–151 (1993).
Kaplan, G. J., Clark, P. S., Bender, T. R., Feltz, E. T., Listyoung, B., Nevius, S. E., and Chin, T. D. Y., Echovirus type 30 meningitis and related febrile illness: Epidemiologic study of an outbreak in an Eskimo community, Am. J. Epidemiol. 92: 257–265 (1970).
Kaplan, M. H., Klein, S. W., Mcphee, J., and Harper, R. G., Group B coxsackievirus infections in infants younger than three months of age: A serious childhood illness, Rev. Infect. Dis. 5: 1019–1032 (1983).
Kapsenberg, J., Picomaviridae: The Enteroviruses, in: Laboratory Diagnosis of Infectious Diseases, Vol. 2, (E. H. Lennette, P. Halonen, and F. A. Murphy, Eds.), pp. 692–722, Springer-Verlag, New York, 1988.
Kapsenberg, J. G., Ras, A., and Korte, J., Improvement of enterovirus neutralization by treatment with sodium deoxycholate or chloroform, Intervirology 12: 329–334 (1979).
Kedmi, S., and Katzenelson, E., A rapid quantitative fluorescent antibody assay of polioviruses using tragacanth gum, Arch. V irol. 56: 337–340 (1978).
Kelly, S., Winsser, J., and Winkelstein, W., JR., Poliomyelitis and other enteric viruses in sewage, Am. J. Public Health 47: 72–77 (1957).
Kennett, M. L., Birch, C. J., Lewis, R A., Yung, A. P., Locarnini, S. A., and Gust, I. D., Enterovirus type 71 infection in Melbourne, Bull. WHO 51: 609–615 (1970).
KEw, O. M., and Notray, B. K., Molecular epidemiology of polioviruses, Rev. Infect. Dis. 6 (Suppl. 2): S499–5504 (1984).
KEw, O. M., Norfay B. K., Hatch, M. H., Hierholzer, J. C., and Osueski, J. F., Oligonucleotide fingerprint analysis of enterovirus 70 isolates from the 1980 to 1981 pandemic of acute hemorrhagic conjunctivitis: Evidence for a close genetic relationship among Asian and American strains, Infect. Immun. 41: 631–635 (1983).
Kibrick, S., Current status of Coxsackie and ECHO viruses in human disease, Prog. Med. Viral. 6: 27–70 (1964).
Kimfarley, R. J., Schonberger, L. B., Nkowane, B. M., Kew, O. M., Bart, K. J., Orenstein, W. A., Hinman, A. R., Hatch, M. H., and Kaplan, J. E., Poliomyelitis in the USA: Virtual elimination of disease caused by wild virus, Lancet 2: 1315–1317 (1984).
King, M. L., Bidwell, D., Shaikh, A., Voller, A., and Banatvala, J. E., Coxsackie B virus specific IgM responses in children with insulin-dependent (juvenile-onset; type 1) diabetes mellitus, Lancet 1: 1397–1399 (1983).
Krramura, N., Semler, B. L., Rothberg, P. G., Larsen, G. R., Adler, C. J., Dorner, A. J., Emini, E. A., Hanecak, R., Lee, J. J., Van Der Werf, S., Anderson, C. W., and Wimmer, E., Primary structure, gene organization, and polypeptide expression of poliovirus RNA, Nature 291: 547–553 (1981).
Kjellen, L., and Von Zeipel, G., Influence of host cells on the infectivity and neutralizability of echovirus type 4 (Pesascek), Intervirology 22: 32–40 (1984).
Klingel, K., Hohenadl, C., Canu, A., Albrecht, M., Seemann, M., Mall, G., and Kandolf, R., Ongoing enterovirusinduced myocarditis is associated with persistent heart muscle infection: Quantitative analysis of virus replication, tissue damage, and inflammation, Proc. Natl. Acad. Sci. USA 89: 314–318 (1992).
Koch, R, and Koch, G., The Molecular Biology of Poliovirus, Springer-Verlag, New York, 1985.
Kogon, A., Spigland, I., Frothingham, T. C., Elveback, L., Williams, C., Hall, C. E., and Fox, J. P., The Virus Watch Program: A continuing surveillance of viral infections in metropolitan New York families. Vii. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackievirus and echovirus infections, Am. J. Epidemiol. 89: 51–61 (1969).
Koike, S., Ise, I., Sato, Y., Mitsui, K., Horie, H., Umeyama, H., and Nomoto, A., Early events of poliovirus infection, Semin. Viral. 3: 109–115 (1992).
Kono, R., Apollo 11 disease or acute hemorrhagic conjuctivitis: A pandemic of a new enterovirus infection of the eyes, Am. J. Epidemiol. 101: 383–390 (1975).
Kono, R., Miyamura, K., Tajiri, E., Sasagawa, A., Phuapradit, P., Roongwithu, N., Vejjajiva, A., Jayavasu, C., Thongcharoen, P., Wasi, C., and Rodprassert, P, Virological and serological studies of neurological complications of acute hemorrhagic conjunctivitis in Thailand, J. Infect. Dis. 135: 706–713 (1977).
Kono, R., Miyamura, K., Tajiri, E., Shiga, S., Sasagawa, A., Irani, P. E, Katrak, S. M., and Wadia, N. H., Neurologic complications associated with acute hemorrhagic conjunctivitis virus infection and its serological confirmation, J. Infect. Dis. 129: 590–593 (1974).
Kong, R., Sasagawa, A., Ishii, K., Sugiura, S., Ochi, M., Matsumiya, H., Uchida, Y., Kameyama, K., Kaneko, M., and Sakurai, N., Pandemic of new type of conjunctivitis, Lancet 1: 1191–1194 (1972).
Kong, R., Sasagawa, A., Miyamura, K., and Taiiri, E., Serologic characterization and sero-epidemiologic studies on acute hemorrhagic conjunctivitis (Ahc) virus, Am. J. Epidemiol. 101: 444–457 (1975).
Kraft, L. M., and Melnick, J. L., Complement fixation tests with homologous and heterologous types of Coxsackie virus in man, J. Immunol. 68: 297–310 (1952).
Kraft, L. M., and Melnick, J. L., Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. II. The development of complement-fixing antibodies, J. Exp. Med. 97: 401–414 (1953).
Krah, D. L., and Crowell, R. L., A solid-phase assay of solubilized HeLa cell membrane receptors for binding group B coxsackieviruses and polioviruses, Virology 118: 148–156 (1982).
Kuritsky, J. N., Weaver, J. H., Bernard, K. W., Mokhbat, J. E., Hatch, M. H., Osterholm, M. T., and Patriarca, P. A., An outbreak of acute hemorrhagic conjunctivitis in central Minnesota, Am. J. Ophthalmol. 96: 449–452 (1983).
Laforce, E M., Lichnevski, M. S., Keja, J., and Henderson, R. H., Clinical survey techniques to estimate prevalence and annual incidence of poliomyelitis in developing countries, Bull. WHO 58: 609–620 (1980).
Lake, A. M., Lauer, B. A., Clark, J. C., Wesenberg, R. L., and Mcintosh, K., Enterovirus infections in neonates, J. Pediatr. 89: 787–791 (1976).
Lamb, G. A., Chin, T. D. Y., and Scarce, L. E., Isolations of enteric viruses from sewage and river water in a metropolitan area, Am. J. Hyg. 80: 320–327 (1964).
Landsteiner, K., and Popper, E., Ubertragung der Poliomyelitis acute auf Affen, Z. Immunitaetsforsch. Orig. 2: 377–390 (1909).
Lansdown, A. B. G., Viral infections and diseases of the heart, Prog. Med. Virol. 24: 70–113 (1978).
Lapinleimu, K., Killed polio virus vaccine in the control of poliomyelitis in Finland, Ann. Clin. Res. 144: 199–203 (1982).
Lasch, E. E., Abed, Y., Abdulla, K., EL Tibbi, A. G., Marcus, O., EL Massri, M., Handscher, R., Gerichter, C. B., and Melnick, J. L., Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza, Rev. Infect. Dis. 6 (Suppl. 2): S467–5470 (1984).
Lad, R. C. H., Coxsackie B virus infections in New Zealand patients with cardiac and noncardiac diseases, J. Med. Virol. 11: 131–137 (1983).
Lavinder, C. H., Freeman, A. W., and Frost, W. H., Epidemiologic studies of poliomyelitis in New York City and Northeastern United States during the year 1916, Public Health Bull. 91: 1–309 (1918).
Lee H. S., Boulilier, J E, Macdonald, M. A., and Forward, K. E., A novel approach to enterovirus typing, J. Med. Virol. 35: 128–132 (1991).
Leinikki, P. O., Pasternack, A., Mustonen, J., Tanuianpaa, P., and Hygty, H., Paralytic poliomyelitis in Finland, Lancet 2: 507 (1985).
Lemon, S. M., and Robertson, S. E., Global eradication of poliomyelitis: Recent progress, future prospects, and new research priorities, Prog. Med. Virol. 38: 42–55 (1991).
Leonardi, G. P., Greenberg, A. J., Costello, P., and Szabo, K., Echovirus type 30 infection associated with aseptic meningitis in Nassau County, New York, USA, Intervirology 36: 53–56 (1993).
Lerner, A. M., Coxsackievirus myocardiopathy, J. Infect. Dis. 120: 496–499 (1969).
Lerner, A. M., Myocarditis and pericarditis, in: International Textbook of Medicine (A. I. Braude, Ed.), pp. 1520–1530, W. B. Saunders, Philadelphia, 1981.
Lerner, A. M., and Wilson, F. M., Virus myocardiopathy, Prog. Med. Virol. 15: 63–91 (1973).
Lim, K. A., and Benyesh-Melnick, M., Typing of viruses by combinations of antiserum pools: Application to typing of enteroviruses (Coxsackie and echo), J. Immunol. 84: 309–317 (1960).
Lim, K. H., and Yin-Murphy, M., An epidemic of conjunctivitis in Singapore in 1970, Singapore Med. J. 12: 247–249 (1971).
Lim, K. H., and Yin-Murphy, M., The aetiologic agents of epidemic conjunctivitis, Singapore Med. J. 18: 41–43 (1977).
Lin, K.-H. Wang, H.-L., Sheu, M.-M., Huang, W.-L., Chen, C.-W., Yang, C.-S., Takeda, N., Kato, N., Miyamura, K., and Yamwzaxl, S., Molecular epidemiology of a variant of coxsackievirus A24 in Taiwan: Two epidemics caused by phylogenetically distinct viruses from 1985 to 1989, J. Clin. Microbiol. 31: 1160–1166 (1993).
Lund, E., Hedstroo., A comparison between virus isolations from sewage and from fecal specimens from patients, Am. J. Epidemiol. 84: 282–286 (1966).
Macleod, D. R. E., Ing, W. K., Belcourt, R. J.-P., Pearson, E. W., and Bell, J. R., Antibody status to poliomyelitis, measles, rubella, diphtheria and tetanus, Ontario, 1969–70: Deficiencies discovered and remedies required, Can. Med. Assoc. J. 113: 619–623 (1975).
Magrath, D. I., Evans, D. M. A., Ferguson, M., Schild, G. C., Minor, P.D., Horaud, F., Crainic, R., Stenvik, M., and Hovi, T., Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated population, J. Gen. Virol. 67: 899–905 (1986).
Maguire, T., The laboratory transmission of Coxsackie A6 virus by mosquitoes, J. Hyg. 68: 625–630 (1970).
Mapoles, J. E., Krah, D. L., and Crowell, R. L., Purification of a HeLa cell receptor protein for group B coxsackieviruses, J. Virol. 55: 560–566 (1985).
Martino, T. A., Sole, M. J., Penn, L. Z., Liew, C.-C., and Liu, P., Quantitation of enteroviral RNA by competitive polymerase chain reaction, J. Clin. Microbiol. 31: 2634–2640 (1993).
Matthews, R. E. F., Classification and nomenclature of viruses. Fourth Report of the International Committee on Taxonomy of Viruses, Intervirology 17: 1–199 (1982).
Mcallister, R. M., Melnyk, J., Finkelstein, J. Z., Adams, E. C., JR., and Gardner, M. B., Cultivation in vitro of cells derived from a human rhabdomyosarcoma, Cancer 24: 520–526 (1969).
Mcbean, A. M., Thomas, M. L., Johnson, R. H., Gadless, B. R., Macdonald, B., Nerhood, L., Cummins, P., Hughes, J., Kinnear, J., Watts, C., Kraft, M., Albrecht, P., Boone, E. J., Moore, M., Frank, J. A., JR., and Bernier, R., A comparison of the serologic responses to oral and injectable trivalent polio- virus vaccines, Rev. Infect. Dis. 6 (Suppl. 2): S552–5555 (1984).
Mccarroll, J. R., Melnick, J. L., and Horstmann, D. M., Spread of poliomyelitis infection in nursery schools, Am. J. Publ. Health 45: 1541–1550 (1955).
Mease, P. J., Ochs, H. D., Corey, L., Dragavon, J., and Wedgewood, R. J., Echovirus encephalitis/myositis in X-linked agammaglobulinemia, N. Engl. J. Med. 313: 758 (1985).
Melchers, W., DE Visser, M., Jongen, P., Van Loon, A., Nibbeling, R., Oostvogel, P, Willemse, D., and Galama, J., The postpolio syndrome: No evidence for poliovirus persistence, Ann. Neurol. 32: 728–732 (1992).
Melnick, J. L., Poliomyelitis virus in urban sewage in epidemic and in non-epidemic times, Am. J. Hyg. 45: 240–253 (1947).
Melnick, J. L., Variation in poliomyelitis virus on serial passage through tissue culture, Cold Spring Harbor Symp. Quant. Biol. 18: 278–279 (1953).
Melnick, J. L., Application of tissue culture methods to epidemiological studies of poliomyelitis, Am. J. Public Health 44: 571–580 (1954).
Melnick, J. L., Antigenic crossings within poliovirus types, Proc. Soc. Exp. Biol. Med. 89: 131–133 (1955).
Melnick, J. L., ECHO viruses, in: Cellular Biology, Nucleic Acids, and Viruses, Special Publications of the New York Academy of Sciences, Vol. 5, (Thomas M. Rivers, Consulting Ed.), pp. 365–381, New York Academy of Sciences, New York, 1957.
Melnick, J. L., Advances in the study of the enteroviruses, Prog. Med. Virol. 1: 59–105 (1958).
Melnick, J. L., Population genetics applied to live poliovirus vaccine, Am. J. Publ. Health 52: 472–483 (1962).
Melnick, J. L., Echoviruses, in: Viral and Rickettsial Infections of Man, 4th ed. (F. L. Horsfall, JR., and I. Tamm, Eds.), pp. 513–545, J. B. Lippincott, Philadelphia, 1965.
Melnick, J. L., Enteroviruses: Vaccines, epidemiology, diagnosis, and classification, CRC Crit. Rev. Clin. Lab. Sci. 1: 87–118 (1970).
Melnick, J. L., Periodic serological surveillance, in: Serological Epidemiology, (J. R. Paul and C. White, Eds.), pp. 142–154, Academic Press, New York, 1973.
Melnick, J. L., Reference materials in virology: The enterovirus example, in: Proceedings International Conference on Standardization of Diagnostic Materials, pp. 213–235, Centers for Disease Control, Atlanta, 1974.
Melnick, J. L., Report to the World Health Organization: Recommendations for the Control of Poliomyelitis in Israel, West Bank and Gaza Strip, Report No. EM/Vir/7, Epid/54, World Health Organization, Geneva, 1977.
Melnick J. L., Advantages and disadvantages of killed and live poliomyelitis vaccines, Bull. WHO 56: 21–38 (1978).
Melnick, J. L., Towards the eradication of poliomyelitis, in: Medical Virology: Proceedings International Symposium on Medical Virology, (L. M. DE LA Maza and E. M. Peterson, Eds.), pp. 261–299, Elsevier Biomedical, New York, 1982.
Melnick, J. L., Portraits of viruses: The picomaviruses, Intervirology 20: 61–100 (1983).
Melnick, J L, Enterovirus type 71 infections: A varied clinical pattern sometimes mimicking paralytic poliomyelitis, Rev. Infect. Dis. 6 (Suppl. 2): 5387 - S390 (1984).
Melnick, J. L., New approaches to hepatitis B vaccines, in: New Approaches to Vaccine Development (R. Bell and G. Torrigiani, Eds.), pp. 218–236, Schwabe & Co., Basel, 1984.
Melnick, J. L. (ED.), Enteric Viruses in Water, Monographs in Virology, Vol. 15, S. Karger, Basel, 1984.
Melnick, J. L., Etiologic agents and their potential for causing waterborne virus diseases, in: Enteric Viruses in Water: Monographs in Virology, Vol. 15, (J. L. Melnick, Ed.), pp. 1–16, S. Karger, Basel, 1984.
Melnick, J. L., Recent developments in the worldwide control of poliomyelitis, in: Control of Virus Diseases (E. Kurstak and R. G. Marusyk, Eds.), pp. 3–31, Marcel Dekker, New York, 1984.
Melnick, J. L., Enteroviruses, in: Laboratory of Diagnosis of Viral Infections (E. H. Lennette, Ed.), pp. 241–256, Marcel Dekker, New York, 1985.
Melnick, J. L., Poliomyelitis: Eradication in sight, Epidemiol. Infect. 108: 1–18 (1992).
Melnick, J. L., Enteroviruses, in: Manual of Clinical Laboratory Immunology, 4th ed. (N. R. Rose, E. C. Macario, J. L. Fahey, H. Friedman, and G. M. Penn, Eds.), pp. 631–633, Washington, DC, American Society for Microbiology, 1992.
Melnick, J. L., Properties and classification of hepatitis A virus, Vaccine 10 (Suppl. 1): 24–26 (1992).
Melnick, J. L., Live attenuated poliovaccines in: Vaccines, 2nd ed. (S. A. Plotkin and E. A. Mortimer, JR., Eds.), pp. 155–204, W. B. Saunders, Philadelphia, 1993.
Melnick, J. L., Agol, V. I., Bachrach, H. L., Brown, F., Cooper, P. D., Fiers, W., Gard, S., Gear, J. H. S., Ghendon, Y., Kasza, L., Laplaca, M., Mandel, B., Mcgregor, S., MoHanty, S. B., Plummer, G., Rueckert, R. R., Schaffer, E L., Tagaya, L, Tyrrell, D. A. J., Voroshilova, M., and Wenner, H., Picomaviridae, Intervirology 4: 303–316 (1974).
Melnick, J. L., and Agren, K., Poliomyelitis and Coxsackie viruses isolated from normal infants in Egypt, Proc. Soc. Exp. Biol. Med. 81: 621–624 (1952).
Melnick, J. L., Ashkenazi, A., Midulla, V. C., Wallis, C., and Bernstein, A., Immunogenic potency of MgC12 stabilized oral poliovaccine, J.A.M.A. 185: 406–408 (1963).
Melnick, J. L., Clarke, N. A., and Kraft, L. M., Immunological reactions of the Coxsackie viruses. Iii. Cross-protection tests in infant mice born of vaccinated mothers. Transfer of immunity through the milk, J. Exp. Med. 92: 499–505 (1950).
Melnick, J. L., Cockburn, W. C., Dalldorf, G., Gard, S., Gear, J. H. S., Hammon, W., McD., Kaplan, M. M., Nagler, F. P., Oker-Blom, N., Rhodes, A. J., Sabin, A. B., Verlinde, J. D., and Von Magnus, H., Picornavirus group, Virology 19: 114–116 (1963).
Melnick, J. L., Crowther, D., and Barrera-Oro, J., Rapid development of drug-resistant mutants of poliovirus, Science 134: 557 (1961).
Melnick, J. L., Dalldorf, G., Enders, J. E, Hammon, W. McD., Sabin, A. B., Syverton, J. T., and Wenner, H. A., The enteroviruses, Am. J. Publ. Health 47: 1556–1566 (1957).
Melnick, J. L., and Dow, R. P., Poliomyelitis in Hidalgo County, Texas, 1948. Poliomyelitis and Coxsackie viruses from flies, Am. J. Hyg. 58: 288–309 (1953).
Melnick, J. L., Emmons, J., Coffey, J. H., and Schoof, H., Seasonal distribution of Coxsackie viruses in urban sewage and flies, Am. J. Hyg. 59: 164–184 (1954).
Melnick, J. L., and Gerba, C. P., The ecology of enteroviruses in natural waters, CRC Crit. Rev. Environ. Control 10: 65–93 (1980).
Melnick, J. L., Gerba, C. P., and Wallis, C., Viruses in water, Bull. WHO 56: 499–508 (1978).
Melnick, J. L., and Hampil, B., WHO collaborative studies on enterovirus reference antisera: Fourth report, Bull. WHO 48: 381–396 (1973).
Melnick, J. L., and Ledinko, N., Social serology: Antibody levels in a normal young population during an epidemic of poliomyelitis, Am. J. Hyg. 54: 354–382 (1951).
Melnick, J. L., and Ledinko, N., Development of neutralizing antibodies against the three types of poliomyelitis virus during an epidemic period: The ratio of inapparent infection to clinical poliomyelitis, Am. J. Hyg. 58: 207–222 (1953).
Melnick, J. L., Mccarroll, J. R., and Horstmann, D. M., A winter outbreak of poliomyelitis in New York City: The complement-fixation testas an aid in rapid diagnosis, Am. J. Hyg. 63: 95–114 (1956).
Melnick, J. L., Paul, J. R., and Walton, M., Serologic epidemiology of poliomyelitis, Am. J. Publ. Health 45: 429–437 (1955).
Melnick, J. L., and Penner, L. R., The survival of poliomyelitis and Coxsackie viruses following their ingestion by flies, J. Exp. Med. 96: 255–271 (1951).
Melnick, J. L., Proctor, R. O., Ocampo, A. R., Diwan, A. R., and Ben-Porath, E., Free and bound virus in serum after administration of oral poliovirus vaccine, Am. J. Epidemiol. 84: 329–342 (1966).
Melnick, J. L., Rennick, V., Hampil, B., Schmidt, N. J., and HO, H. H., Lyophilized combination pools of enterovirus equine antisera: Preparation and test procedures for the identification of field strains of 42 enteroviruses, Bull. WHO 48: 263–268 (1973).
Melnick, J. L., Safferman, R., Rao, V. C., GoyAL, S., Berg, Q., Dahling, D. R., Wright, B. A., Akin, E., Stetler, R., Sorber, C., Moore, B., Sobsey, M. D., Moot, R., Lewis, A. L., and Wellings, F. M., Round robin investigation of methods for the recovery of poliovirus from drinking water, Appl. Environmental Microbiol. 47: 144–150 (1984).
Melnick, J. L., Schmidt, N. J., Hampil, B., and Ho, H. H., Lyophilized combination pools of enterovirus equine antisera: Preparation and test procedures for the identification of field strains of 19 group A coxsackievirus serotypes, Intervirology 8: 172–181 (1977).
Melnick, J. L., Schmidt, N. J., Mirkovic, R. R., Chumakov, M. P., Lavrova, I. K., and Voroshilova, M. K., Identification of Bulgarian strain 258 of enterovirus 71, Intervirology 12: 297–302 (1979).
Melnick, J. L., Shaw, E. W., and Curnen, E. C., A virus from patients diagnosed as non-paralytic poliomyelitis or aseptic meningitis, Proc. Soc. Exp. Biol. Med. 71: 344–349 (1949).
Melnick, J. L., Tagaya, l., and Von Magnus, H., Enteroviruses 60, 70, and 71, Intervirology 4: 369–370 (1974).
Melnick, J. L., and Wenner, H. A., Enteroviruses, in: Diagnostic Procedures for Viral and Rickettsial Diseases, 4th ed. (E. H. Lennette and N. J. Schmidt, Eds.), pp. 529–602, American Public Health Association, Washington, DC, 1969.
Melnick, J. L., Wenner, H. A., and Phillips, C. A., Enteroviruses, in: Diagnostic Procedures for Viral, Rickettsial, and Chlamydia) Infections, 5th ed. (E. H. Lennette and N. J. Schmidt, Eds.), pp. 471–534, American Public Health Association, Washington, DC, 1979.
Melnick, J. L., Wenner, H. A., and Rosen, L., The enteroviruses, in: Diagnostic Procedures for Viral and Rickettsial Diseases, 3rd ed. (E. H. Lennette and N. J. Schmidt, Eds.), pp. 194–242, American Public Health Association, Washington, DC, 1964.
Melnick, J. L., and Wimberly, I. L., Lyophilized combination pools of enterovirus equine antisera: New Lbm pools prepared from reserves of antisera stored frozen for two decades, Bull. WHO 63: 543–550 (1985).
Menegus, M. A., Enteroviruses, in: Manual of Clinical Microbiology, 4th ed. (E. H. Lennette, Ed.), pp. 743–746, American Society for Microbiology, Washington, DC, 1985.
Menegus, M. A., and Hollick, G. E., Increased efficiency of group B coxsackievirus isolation from clinical specimens by use of BGM cells, J. Clin. Microbiol. 15: 945–948 (1982).
Metcalf, T. G., and Melnick, J. L., Simple apparatus for collecting estuarine sediments and suspended solids to detect solids-associated virus, Appl. Environ. Microbiol. 45: 323–327 (1983).
Metcalf, T. G., Rao, V. C., and Melnick, J. L., Solid-associated viruses in a polluted estuary, in: Enteric Viruses in Water: Monographs in Virology, Vol. 15, (J. L. Melnick, Ed.), pp. 97–110, S. Karger, Basel, 1984.
Miller, D. A., Miller, O. J., Vaithilingham, G. D., Hashmi, S., Tantravahi, R., Medrano, L., and Green, H., Human chromosome 19 carries a poliovirus receptor gene, Cell1: 167–173 (1974).
Minor, P. D., Review article: The molecular biology of polio-vaccines, J. Gen. Virol. 74: 3065–3077 (1992).
Minor, P. D., Evans, D. M. A., Ferguson, M., Schild, G. C., Westrop, G., and Almond, J. W., Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3, J. Gen. Virol. 65: 1159–1165 (1985).
Mirchamsy, H., Shafyi, A., Mahinpour, M., and Nazari, P., Stabilizing effect of magnesium chloride and sucrose on Sabin live polio vaccine, in: Vaccinations in the Developing Countries, Developments in Biological Standardization, (R. H. Reganey, Acting Ed.), Vol. 41, pp. 255–257, S. Karger, Basel, 1978.
Mirkovic, R. R., KoNO, R., Yin-Murphy, M., Sohier, R., Schmidt, N. J., and Melnick, J. L., Enterovirus type 70: The etiologic agent of pandemic acute haemorrhagic conjunctivitis, Bull. WHO 49: 341–346 (1973).
Mirkovic, R. R., Schmidt, N. J., Yinmurphy, M., and Melnick, J. L., Enterovirus etiology of the 1970 Singapore epidemic of acute conjunctivitis, Intervirology 4: 119–127 (1974).
Miwa, C., Yamada, F, Matsuura, A., and Yoshizawa, K., Epidemic of hand, foot and mouth disease in Gifu prefecture in 1973, Virus 28: 78–86 (1978).
Miyamura, K., Yamashita, K., Yamadera, S., Kato, N., Akatsuka, M., and Yamazaki, S., An epidemic of echovirus 18 in Japan-High association with clinical manifestation of exanthem, Jpn. J. Med. Sci. Biol. 43: 51–58 (1990).
Miyalvlura, K., Yamashita, K., Yamadera, S., Kato, N., Akatsuka, M., Hara, M., Inouye, S., and Yamazaki, S., Poliovirus surveillance: Isolation of polioviruses in Japan, 1980–1991, Jpn. J. Med. Sci. Biol. 45: 203–214 (1992).
Modlin, J. F, Perinatal echovirus infection: Insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries, Rev. Infect. Dis. 8: 918–926 (1986).
Modlin, J. F, Polk, B. F., Horton, P., Etkind, P., Crane, E., and Spiliotes, A., Perinatal echovirus infection: Risk of trans-mission during a community outbreak, N. Engl. J. Med. 305: 368–371 (1981).
Moore, M., From the Centers for Disease Control: Enteroviral disease in the United States, 1970–1979, J. Infect. Dis. 146: 103–108 (1982).
Moore, M., Baron, R. C., FI[Stein, M. R., Lofgren, J. P., Rowley, D. L., Schonberger, L. B., and Hatch, M. H., Aseptic meningitis and high school football players, 1978–1980, J.A.M.A. 249: 2039–2042 (1983).
Moore, M., and Morens, D. M., Enteroviruses, including polioviruses, in: Textbook of Human Virology, 2nd ed. (R. B. Bel-She, ed.), pp. 407–483, Psg Publishing Co., Littleton, MA, 1984.
Morens, D. M., Poliovaccine strategy, Lancet 1: 285–286 (1985).
Morens, D. M., Pallansch, M. A., and Moore, M., Polioviruses and other enteroviruses, in: Textbook of Human Virology, 2nd ed. (R. B. Belshe, Ed.), pp. 427–497, Mosby Year Book, St. Louis, MO, 1990.
Morrison, L. A., and Fields, B. N., Minireview: Parallel mechanisms in neuropathogenesis of enteric virus infections, J. Virol. 65: 2767–2772 (1991).
Muir, P., and Kandolf, R., The laboratory diagnosis of enterovirus-induced heart disease, in: Viral Infections of the Heart, (J. E. Banatvala, ed.), London, Edward Arnold, pp. 211–230, 1993.
Muir, P., Singh, N. B., and Banatvala, J. E., Enterovirusspecific serum IgA antibody responses in patients with acute infections, chronic cardiac disease, and recently diagnosed insulin-dependent diabetes mellitus, J. Med. Virol. 32: 236–242 (1990).
Muir, P., Nicholson, F., Jhetam, M., Neogi, S., and Banatvala, J. E., Rapid diagnosis of enterovirus infection by magnetic bead extraction and polymerase chain reaction detection of enterovirus RNA in clinical specimens, J. Clin. Microbiol. 31: 31–38 (1993).
Nagington, J., Gandy, G., Walker, J., and Gray, J. J., Use of normal immunoglobulin in an echovirus outbreak in a special-care baby unit, Lancet 2: 443–446 (1983).
Nagington, J., Wreghitt, T. G., Gandy, G., Roberton, N. R. C., and Berry, P. J., Fatal echovirus 11 infections in outbreak in special-care baby unit, Lancet 2: 725 (1978).
Nagy, G., Takatsy, S., Kukan, E., Mihaly, I., and Domok, I., Virological diagnosis of enterovirus type 71 infections: Experiences gained during an epidemic of acute Cns diseases in Hungary in 1978, Arch. Virol. 71: 217–227 (1982).
Nakano, J. H., Hatch, M. H., Thieme, M. L., and Nottay, B., Parameters for differentiating vaccine-derived and wild polio-virus strains, Prog. Med. Virol. 24: 178–206 (1978).
Nakao, T., Coxsackie viruses and diabetes, Lancet 2: 1423 (1971).
Narang, H. K., and Codd, A. A., Enterovirus typing by immune electron microscopy using low-speed centrifugation, J. Clin. Pathol. 33: 191–194 (1980).
Nardi, G., Baron’, M., Tanzi, M. L., Grandi, D., Bevilacqua, G., and Tedeschi, F., Epidemic due to group B Coxsackie viruses in a newborn infants’ department, Ann. Sclavo 18: 793–808 (1976).
Nathanson, N., Epidemiologic aspects of poliomyelitis eradication, Rev. Infect. Dis. 6 (Suppl. 2): 308–312 (1984).
Nejmi, S., Gaudin, O. G., Chomel, J. J., Baal, A., Sohier, R., and Bosshard, S., Isolation of a virus responsible for an outbreak of acute haemorrhagic conjunctivitis in Morocco, J. Hyg. 72: 181–183 (1974).
Nicholas, D. D., Kratzer, J. H., Ofosu-Amaah, S., and Belcher, D. W., Is poliomyelitis a serious problem in developing countries?-the Danfa experience, Br. Med. J. 1: 1009–1112 (1977).
Nishmi, M., and Yodfat, Y., Successive overlapping outbreaks of a febrile illness associated with coxsackie virus type B4 and echo virus type 9 in a kibbutz, Israel J. Med. Sci. 9: 895–899 (1973).
Nkowane, B. M., Wassilak, S. G. F., Orenstein, W. A., Bart, K. J., Schonberger, L. B., Hinman, A. R., and Kew, O. M., Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984, J.A.M.A. 257: 1335–1340 (1987).
Nolan, J. P., Wilmer, B. J., and Melnick, J. L., Poliomyelitis: Its highly invasive nature and narrow stream of infection in a community of high socioeconomic level, N. Engl. J. Med. 253: 945–954 (1955).
Nomoto, A., Cellular receptors for virus infection, Semin. Virol. 3: 77–133 (1992).
Nomoto, A., Recombinant polioviruses as candidates for oral live poliovaccines, Microbiol. Immunol. 37: 169–174 (1993).
Nomoto, A., Omata, T., Toyoda, H., Kuge, S., Horie, H., Kataoka, Y., Genba, Y., Nakano, Y., and Imura, N., Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome, Proc. Natl. Acad. Sci. USA 79: 5793–5797 (1982).
Notkins, A. L., Virus-induced diabetes mellitus, Arch. Virol. 54: 1–17 (1977).
Notkins, A. L., and YooN, J. W., Virus-induced diabetes mellitus, in: Concepts in Viral Pathogenesis, ( A. L. Notkins and M. B. A. Oldstone, Eds.), pp. 241–247, Springer-Verlag, New York, 1984.
Nottay, B. K., Kew, O. M., Hatch, M. H., Heyward, J. T., and Obueski, J. F., Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans, Virology 108: 405–423 (1981).
Ofosu-Amaah, S., Kratzer, J. H., and Nicholas, D. D., Is poliomyelitis a serious problem in developing countries? Lameness in Ghanaian schools, Br. Med. J. 1: 1012–1014 (1977).
Ogra, P. L., Mucosal immune response to poliovirus vaccines in childhood, Rev. Infect. Dis. 6 (Suppl. 2): S361 - S368 (1984).
Ogra, P. F., Fishaut, M., and Gallagher, M. R., Viral vaccination via the mucosal routes, Rev. Infect. Dis. 2: 352–369 (1980).
Ogra, P. L., and Karzon, D. T., Formation and function of poliovirus antibody in different tissues, Prog. Med. Virol. 13: 156–193 (1971).
Olive, D. M., Almufti, S., AL-Mulla, W., Khan, M. A., Pasca, A., Staneay, G., and AL-Nakib, W., Detection and differentiation of picornaviruses in clinical samples following genomic amplification, J. Gen. Virol. 71: 2141–2147 (1990).
Omata, T., Kohara, M., Sakai, Y., Kameda, A., Imura, N., and Nomoto, A., Cloned infectious complementary DNA of the poliovirus Sabin I genome: Biochemical and biological properties of the recovered virus, Gene 32: 1–10 (1984).
Orchard, T. J., Atchison, R. W., Becker, D., Rabin, B., Eberhardt, M., Kuller, L. H., Laporte, R. E., and Lavender, D., Coxsackie infection and diabetes, Lancet 2: 631 (1983).
Osterhaus, A. D. M. E., Van Wezel, A L, Hazendonk, T. G., Uytedehaag, F. G. C. M., Van Aste, J. A. A. M., and Van Steenis, B., Monoclonal antibodies to polioviruses. Comparison of intratypic strain differentiation of poliovirus type 1 using monoclonal antibodies versus cross-absorbed antisera, Intervirology 20: 129–136 (1983).
Osterhaus, A. D. M. E., Van Wezel, A. L., Van Steenis, B., Drost, G. A., and Hazendonk, A. G., Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains, Intervirology 16: 218–224 (1981).
Pacsa, S., and Werblinska, J., Natural immunity of Ghanaian children to polio and coxsackieviruses: Brief report, Arch. Virusforsch. 33: 192–193 (1971).
Pal, S. R., Szucs, G., and Melnick, J. L., Rapid immune Chapter 21 Poliovirus and Other Enteroviruses fluorescence diagnosis of acute hemorrhagic conjunctivitis caused by enterovirus 70, Intervirology 20: 19–22 (1983).
Pal, S. R., Szucs, G., Melnick, J. L., Kaiwar, R., Bhardwaj, G., Singh, R., Gangwar, D. N., Choudhury, S., and Jain, I. S., Immunofluorescence test for the epidemiological monitoring of acute haemorrhagic conjunctivitis cases, Bull. WHO 61: 485–490 (1983).
Pan American Health Organization, Live Poliovirus Vaccines, Special Publications of the Pan American Health Organization, Nos. 44 and 50, 1959, 1960.
Paque, R. E., Gauntt, C. J., and Nealon, T. J., Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio), Infect. Immun. 31: 470–479 (1981).
Parks, W. P., Queiroga, L. T., and Melnick, J. L., Studies of infantile diarrhea in Karachi, Pakistan. II. Multiple virus isolations from rectal swabs, Am. J. Epidemiol. 84: 469–478 (1967).
Patriarca, P. A., Onorato, I. M., Sklar, V. E. F., Schon-Berger, L. B., Kaminski, R. M., Hatch, M. H., Morens, D. M., and Forster, R. K., Acute hemorrhagic conjunctivitis. Investigation of a large-scale community outbreak in Dade County, Florida, J.A.M.A. 249: 1283–1289 (1983).
Patriarca, P. A., Wright, P. F., and John, T. J., Factors affecting the intmunogenicity of oral poliovirus vaccine in developing countries: Review, Rev. Infect. Dis. 13: 926–939 (1991).
Paul, J. R., Endemic and epidemic trends of poliomyelitis in Central and South America, Bull. WHO 19: 737–758 (1958).
Paul, J. R., A History of Poliomyelitis, Yalé University Press, New Haven, 1971.
Paul, J. R., Development and use of serum surveys in epidemiology, in: Serological Epidemiology, (J. R. Paul and C. White, eds.), pp. 1–13, Academic Press, New York, 1973.
Paul, J. R., and Melnick, J. L., Poliomyelitis, in: Diagnostic Procedures for Virus and Rickettsial Diseases, 2nd ed. (E. H. Lennette and N. J. Schmidt, eds.), pp. 53–90, American Public Health Association, New York, 1956.
Paul, J. R., Melnick, J. L., Barnett, V. H., and Goldblum, N., A survey of neutralizing antibodies to poliomyelitis in Cairo, Egypt, Am. J. Hyg. 55: 402–413 (1952).
Paul, J. R., Riordan, J. T., and Melnick, J. L., Antibodies to three different antigenic types of poliomyelitis virus in sera from North Alaskan Eskimos, Am. J. Hyg. 54: 275–285 (1951).
Payne, A. M.-M., Poliomyelitis as a world problem, in: Papers and Discussions Presented at the Third International Poliomyelitis Conference, pp. 393–400, J. B. Lippincott, Philadelphia, 1955.
Peetermans, J., Colinet, G., and Stephenne, J., Activity of attenuated poliomyelitis and measles vaccines exposed at different temperatures, in: Proceedings Symposium on Stability and Effectiveness of Measles, Poliomyelitis and Pertussis Vaccines, pp. 61–66, Yugoslav Academy of Sciences and Arts, Zagreb, 1976.
Petersen, I., Polio antibody patterns in the Danish population since 1954, in: Proceedings of the 75th Anniversary Meeting, Statens Serum Instituts, Copenhagen, 1977.
Petitjean, J., Quibriac, M., Freymuth, F., Fuchs, F., Laconche, N., Aymard, M., and Kopecka, H., Specific detection of enteroviruses in clinical samples by molecular hybridization using poliovirus subgenomic riboprobes, J. Clin. Microbiol. 28: 307–311 (1990).
Petitjean, J., Kopecka, H., Freymuth, F., Langlard, J. M., Scanu, P., Galateau, E, Bouhour, J. B., Ferriere, M., Char-Bonneau, P., and Komajda, M., Detection of enteroviruses in endomyocardial biopsy by molecular approach, J. Med. Virol. 37: 76–82 (1992).
Phillips, C. A., Melnick, J. L., Barrett, F. F., Behbehani, A. M., and Riggs, S., Dual virus infections: Simultaneous enteroviral disease and St. Louis encephalitis, J.A.M.A. 197: 169–172 (1966).
Prabhakar, B. S., Haspel, M. V., Mcclintock, P. R., and Notkins, A. L., High frequency of antigenic variants among naturally occurring human coxsackie B4 virus isolates identified by monoclonal antibodies, Nature 300: 374–376 (1982).
Prather, S. L., Dagan, R., Jenista, J. A., and Menegus, M. A., The isolation of enteroviruses from blood: A comparison of four processing methods, J. Med. Virol. 14: 221–227 (1984).
Racaniello, V. R., and Baltimore, D., Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome, Proc. Natl. Acad. Sci. USA 78: 4887–4891 (1981).
Racaniello, V. R., and Baltimore, D., Cloned poliovirus complementary DNA is infectious in mammalian cells, Science 214: 916–918 (1981).
Ramos-Alvarez, M., and Sabin, A. B., Characteristics of poliomyelitis and other enteric viruses recovered in tissue culture from healthy American children, Proc. Soc. Exp. Biol. Med. 87: 655–661 (1954).
Raska, K., Editorial: Epidemiologic surveillance in the control of infectious disease, Rev. Infect. Dis. 5: 1112–1117 (1983).
Redline, R. W., Genest, D. R., and Tycko, B., Detection of enteroviral infection in paraffin-embedded tissue by the RNA polymerase chain reaction technique, Am. J. Clin. Pathol. 96: 569–571 (1991).
Reissig, M., HowES, D. W., and Melnick, J. L., Sequence of morphological changes in epithelial cell cultures infected with poliovirus, J. Exp. Med. 104: 289–304 (1956).
Ren, R., and Racaniello, V. R., Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice, J. Virol. 66: 296–304 (1992).
Reyes, M. P., Ostrea, E. M., JR., Roskamp, J., and Lerner, A. M., Disseminated neonatal echovirus 11 disease following ante- natal maternal infection with a virus-positive cervix and virus- negative gastrointestinal tract, J. Med. Virol. 12: 155–159 (1982).
Rico-Hesse, R., Pallansch, M. A., Nottay, B. K., and Kew, O. M., Geographic distribution of wild poliovirus type 1 genotypes, Virology 160: 311–322 (1987).
Risi, J. B., JR., The control of poliomyelitis in Brazil, Rev. Infect. Dis. 6 (Suppl. 2): S400 - S403 (1984).
Rivers, T. M., and Horsfall, F. L., JR. (Eds.), Viral and Rickettsial Infections of Man, 3rd ed., J. B. Lippincott, Philadelphia, 1959.
Robbins, F. C., Enders, J. F., Weller, T. H., and Florentino, G. L., Studies on the cultivation of poliomyelitis viruses in tissue culture. V. The direct isolation and serologic identification of virus strains in tissue culture from patients with nonparalytic and paralytic poliomyelitis, Am. J. Hyg. 54: 286–293 (1951).
Robbins, F. C., and Nightingale, E. O., Selective primary health care: Strategies for control of disease in the developing world. IX. Poliomyelitis, Rev. Infect. Dis. 5: 957–968 (1983).
Rosen, L., and Kern, J. K., Hemagglutination and hemagglutination-inhibition with Coxsackie B viruses, Proc. Soc. Exp. Biol. Med. 107: 626–628 (1981).
Rosen, L., Melnick, J. L., Schmidt, N. J., and Wenner, H. A., Subclassification of enteroviruses and echovirus type 34, Arch. Virusforsch. 30: 89–92 (1970).
Rosen, L., Schmidt, N. J., and Kern, J., Toluca-1, a newly recognized enterovirus, Arch. Ges. Virusforsch. 40: 132–136 (1973).
Rosenwirth, B., and Eggers, H. J., Biochemistry and pathogenicity of echovirus 9: 1. Characterization of the virus particles of strains Bally and Hill, Virology 123: 102–112 (1982).
Ross, C. A. C., Bell, E. J., Kerr, M. M., and Williams, K. A. B., Infective agents and embryopathy in the West of Scotland 1966–70, Scott. Med. J. 17: 252–258 (1972).
Rossen, R. D., Kasel, J. A., and Couch, R. B., The secretory immune system: Its relation to respiratory viral infection, Prog. Med. Virol. 13: 144–238 (1971).
Rossouw, E., Tsilimigras, C. S. A., and Schoub, B. D., Molecular epidemiology of a coxsackievirus B3 outbreak, J. Med. Virol. 34: 165–171 (1991).
Rotbart, H. A., New methods of rapid enteroviral diagnosis, Prog. Med. Viral. 40: 96–108 (1991).
Rotbart, H. A., Levin, M. J., and Villarreal, L. P., Use of subgenomic poliovirus DNA hybridization probes to detect the major subgroups of enteroviruses, J. Clin. Microbiol. 20: 1105–1108 (1984).
Rueckert, R. R., Picomaviruses and their replication, in: Virology, (B. N. Fields, D. M. Knipe, R. M. Chanock, J. L. Melnick, B. Roizman, and R. E. Shope, Eds.), pp. 705–738, Raven Press, New York, 1985.
Rumke, H. C., Schlumberger, M., Floury, B., Nagel, J., and Van Steenis, B., Serological evaluation of a simplified immunization schedule using quadruple DPT-polio vaccine in Burkina Faso, Vaccine 11: 1113–1118 (1993).
Sabin, A. B., Oral poliovirus vaccine, J.A.M.A. 194: 872–876 (1965).
Sabin, A. B., Paralytic poliomyelitis: Old dogmas and new perspectives, Rev. Infect. Dis. 3: 543–564 (1981).
Sabin, A. B., Oral poliovirus vaccine: History of its development and use and current challenge to eliminate poliomyelitis from the world, J. Infect. Dis. 151: 420–436 (1985).
Sabin, A. B., Hennessen, W. A., and Winsser, J., Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types, J. Exp. Med. 99: 551–576 (1954).
Sabin, A. B., Krumbiegel, E. R., and Wigand, R., ECHO type 9 virus disease: Virologically controlled clinical and epidemiologic observations during 1957 epidemic in Milwaukee with notes on concurrent similar diseases associated with Coxsackie and other ECHO viruses, Am. J. Dis. Child. 96: 197–219 (1958).
Salk, D., Eradication of poliomyelitis in the United States. Iii. Poliovaccines-practical considerations, Rev. Infect. Dis. 2: 258–273 (1980).
Salk, D., and Salk, J., Vaccinology of poliomyelitis: A review, Vaccine 2: 59–74 (1984).
Salk, D., Von Wezel, A. L., and Salk, J., Induction of longterm immunity to paralytic poliomyelitis by use of noninfectious vaccine, Lancet 2: 1317–1321 (1984).
Salk, J. E., Poliomyelitis: Control, in: Viral and Rickettsial Infections of Man, 3rd ed. (T. M. Rivers and E. L. Horsfall, JR., Eds.), pp. 499–518, J. B. Lippincott, Philadelphia, 1959.
Salk, J., One-dose immunization against paralytic poliomyelitis using a noninfectious vaccine, Rev. Infect. Dis. 6 (Suppl. 2): S444 - S450 (1984).
Salk, J., and Salk, D., Control of influenza and poliomyelitis with killed virus vaccines, Science 195: 834–837 (1977).
Samuda, G. M., Chang, W. K., Yeung, C. Y., and Tang, R S., Monoplegia caused by enterovirus 71: An outbreak in Hong Kong, Pediatr. Infect. Dis. 6: 206–208 (1987).
Samuelson, A., Glimaker, M., Skoog, E., Cello, J., and Forsgren, M., Diagnosis of enteroviral meningitis with IgGeia using heat-treated virions and synthetic peptides as antigens, J. Med. Virol. 40: 271–277 (1993).
Sandelin, K., Tuomioja, M., and Erkkila, H., Chovirus type 7 isolated from conjunctival scrapings, Scand J. Infect. bis. 9: 71–73 (1977).
Sawyer, L. A., Hershow, R. C., Pallansch, M. A., Fishbein, D. B., Pinsky, R. F., Broerman, S. E, Grimm, B. B., Anderson, L. J., Hall, D. B., and Schonberger, L. B., An epidemic of acute hemorrhagic conjunctivitis in American Samoa caused by coxsackievirus A24 variant, Am. J. Epidemiol. 130: 1187–1198 (1989).
Schaap, G. J. R, Bukerk, H., Coutinho, R. A., Kapsenberg, J. G., and Van Wezel, A. L., The spread of poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic, Prog. Med. Virol. 29: 124–140 (1984).
Schaffer, E L., Binding of proflavine by and photoinactivation of poliovirus propagated in the presence of the dye, Virology 18: 412–425 (1962).
Scheible, J. H., Fox, V. L., and Lennette, E. H., A probable new human picomavirus associated with respiratory disease, Am. J. Epidemiol. 85: 297–310 (1967).
Schmidt, N. J., Ho, H. H., and Lennette, E. H., Propagation and isolation of group A coxsackieviruses in RD cells, J. Clin. Microbiol. 2: 183–185 (1975).
Schmidt, N. J., Ho, H. H., and Lennette, E. H., Comparative sensitivity of the BGM cell line for isolation of enteric viruses, Health Lab. Sci. 13: 115–117 (1976).
Schmidt, N. J., and Lennette, E. H., Advances in the serodiagnosis of viral infections, Prog. Med. Viral. 15: 244–308 (1973).
Schmidt, N. J., Lennette, E. H., and Ho, H. H., An apparently new enterovirus isolated from patients with disease of the central nervous system, J. Infect. Dis. 129: 304–309 (1974).
Schmidt, N. J., Magoffin, R. L, and Lennette, E. H., Association of group B coxsackieviruses with cases of pericarditis, myocarditis, or pleuordynia by demonstration of immunoglobulin M antibody, Infect. Immun. 8: 341–348 (1973).
Schnurr, D. P., Cao, Y., and Schmidt, N. J., Coxsackievirus B3 persistence and myocarditis in N:Nih(S) II nu/nu and +/nu mice, J. Gen. Virol. 65: 1197–1201 (1984).
Schonberger, L. B., Kaplan, J., Kim-Farley, R., Moore, M., Eddins, D. L., and Hatch, M., Control of paralytic poliomyelitis in the United States, Rev. Infect. Dis. 6 (Suppl. 2): S424 - S426 (1984).
Seal, L. A., and Jamison, R. M., Evidence for secondary structure within the virion RNA of echovirus 22, J. Virol. 50: 641–644 (1984).
Sells, C. J., Carpenter, R. L., and Ray, C. G., Sequelae of central-nervous-system enterovirus infections, J. Engl. J. Med. 293: 1–4 (1975).
Semler, B. L., Dorner, A. J., and Wimmer, E., Production of an infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals, Nucleic Acids Res. 12: 5123–5141 (1984).
Sergiescu, D., Horodniceanu, F., and Aubert-Combiescu, A., The use of inhibitors in the study of picomavirus genetics, Prog. Med. Virol. 14: 123–199 (1972).
Sharief, M. K., Hentges, R., and Ciardi, M., IntratheCal immune response in patients with the post-polio syndrome, New Engl. J. Med. 325: 749–755 (1991).
Shimojo, H., Poliomyelitis control in Japan, Rev. Infect. Dis. 6 (Suppl. 2): S427 - S430 (1984).
Shindarov, L. M., Chumakov, M. P., Vqrd8Hilqna, M. K., BO7lNqv, S., Vasilenko, S. M., Idrdanon, L, Kirov, I. D., Kamenov, E., Leshinskaya, E. V., Mitov, G., Robinson, I. A., Sivchev, S., and Staikov, S., Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71, J. Hyg. Epidemiol. Microbiol. Immunol. 23: 284–295 (1979).
Simmonds, R. S., Szucs, G., Metcalf, T. G., and Melnick, J. L., Persistently infected cultures as a source of hepatitis A virus, Appl. Environ. Microbiol. 49: 749–755 (1985).
Skeels, M. R., Williams, J. J., and Ricker, F. M., Perinatal echovirus infection, N. Engl. J. Med. 305: 1529 (1981).
Slater, P. E., Orenstein, W. A., Morag, A., Avni, A., Handsher, R., Green, M. S., Costin, C., Yarrow, A., Rishpon, S., Havkin, O., Ben-Zvi, T., Kew, O. M., Rey, M., Epstein, I., Swartz, T. A., and Melnick, J. L., Poliomyelitis outbreak in Israel in 1988: A report with two commentaries, Lancet 335: 1192–1198 (1990).
Sohier, R., Enterovirus type 71 surveillance: France, WHO Week Epidemiol. Rec. 54: 219 (1979).
Sommerville, R G, Rapid diagnosis of viral infections by immunofluorescent staining of viral antigens in leukocytes and macrophages, Prog. Med. Virol. 10: 398–414 (1968).
Stoeckel, P., Schlumberger, M., Parent, G., Maire, B., Van Wezel, A, Van Steenis, G., Evans, A., and Salk, D., Use of killed poliovirus vaccine in a routine immunization program in West Africa, Rev Infect. Dis. 6 (Suppl. 2): S463 - S466 (1984).
Summers, D. F., and Maizel, J V., JR., Evidence for large precursor proteins in poliovirus synthesis, Proc. Natl. Acad. Sci. USA 59: 966–971 (1968).
Sutmoller, F., Nascimento, J. P., Chaves, J. R. S., Ferreira, V., and Pereira, M. S., Viral etiology of acute respiratory diseases in Rio de Janeiro: First two years of a longitudinal study, Bull. WHO 49: 129–137 (1983).
Taber, L. H., Mirkovic, R. R., Adam, V., Ellis, S., Yow, M. D., and Melnick, J. L., Rapid diagnosis of enterovirus meningitis by immunofluorescent staining of Csf leukocytes, Intervirology 1: 127–134 (1973).
Tagaya, I., Nakao, C., Hara, M., and Yamadera, S., Characterization of poliovirus isolates in Japan after the mass vaccination with live oral poliomyelitis vaccine (Sabin), Bull. WHO 48: 547–554 (1973).
Takatsu, T., Tagaya, I., and Hirayama, M., Poliomyelitis in Japan during the period 1961–1968 after the introduction of mass vaccination with Sabin vaccine, Bull. WHO 49: 129–137 (1973).
Tamm, I., and Eggers, H. J., Differences in the selective virus-inhibitory action of 2-(a-hydroxybenzyl)-benzimidazole and guanidine. HC1, Virology 18: 439–447 (1962).
Tilzey, A. J., Signey, M., and Banatvala, J. E., Persistent coxsackie B virus specific IgM response in patients with recurrent pericarditis, Lancet 1: 1491–1492 (1986).
Torfason, E. G., Frisk, G., and Diderholm, H., Indirect and reverse radioimmunoassays and their apparent specificities in the detection of antibodies to enteroviruses in human sera, J. Med. Virol. 13: 13–31 (1984).
Torphy, D. E., Ray, C. G., Thompson, R. S., and Fox, J. P., An epidemic of aseptic meningitis due to echovirus type 30: Epidemiological features and clinical laboratory findings, Am. J. Public Health 60: 1447–1455 (1970).
Townsend, T. R., Bolyard, E. A., Yolken, R. H., Beschorner, W. E., Bishop, C. A., Burns, W. H., Santos, G. W., and Saral, R., Outbreak of coxsackie Al gastroenteritis: A complication of bone-marrow transplantation, Lancet 1: 820–823 (1982).
Trask, J. D., Melnick, J. L., and Wenner, H. A., Chlorination of human, monkey-adapted and mouse strains of poliomyelitis virus, Am. J. Hyg. 41: 30–40 (1945).
Tulchinsky, T. H., Handsher, R., Melnick, J. L., Shabaan, D. A., Neumann, M., Abed, Y, and Budnitz, D., Immune status to various strains of wild poliovirus among children in Gaza immunized with live attenuated oral vaccine alone compared with combination of live and inactivated vaccines, J. Viral Dis. 1: 1–9 (1993).
Ukkonen, P., Huovilainen, A., and Hoyt, T., Detection of poliovirus antigen by enzyme immunoassay, J. Clin. Microbiol. 24: 954–958 (1986).
Vallbracht, A., Hofmann, L., Wurster, K. G., and Flehmig, B., Persistent infection of human fibroblasts by hepatitis A virus, J. Gen. Virol. 65: 609–615 (1984).
Van Der Werf, S., Bregegere, F., Kopecka, H., Kitamura, N., Rothberg, P. G., Kourilsky, P., Wimmer, E., and Girard, M., Molecular cloning of the genome of poliovirus type 1, Proc. Natl. Acad. Sci. USA 78: 5983–5987 (1981).
Van Der Werf, S., Wychowski, C., Bruneau, P., Blondel, B., Crainic, R., Horodniceanu, E, and Girard, M., Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1, Proc. Natl. Acad. Sci. USA 80: 5080–5084 (1983).
Van Wezel, A. L., and Hazendonk, A. G., Intratypic serodifferentiation of poliomyelitis virus strains by strain-specific antisera, Intervirology 11: 2–8 (1979).
Van Wezel, A. L., Van Steenis, G., Van Der Marel, P., and Osterhaus, A. D. M. E., Inactivated poliovirus vaccine: Current production methods and new developments, Rev. Infect. Dis. 6 (Suppl. 2): S335 - S340 (1984).
vox Magnus, H., Polio vaccination in Denmark, in: Report of the Committee for the Study of Poliomyelitis Vaccines, Institute of Medicine, National Academy of Sciences USA, 1977.
Von Magnus, H., and Petersen, I., Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark, Rev. Infect. Dis. 6 (Suppl. 2): S471 - S474 (1984).
Voroshilova, M. K., and Chumakov, M. P., Poliomyelitis-like properties of AB-IV-Coxsackie A7 group of viruses, Prog. Med. Virol. 2: 106–170 (1959).
Wadia, N. H., Irani, P. F., and Katrak, S. M., Lumbosacral radiculomyelitis associated with pandemic acute haemorrhagic conjunctivitis, Lancet 1: 350–352 (1973).
Wallis, C., Homma, A., and Melnick, J. L., A portable virus concentrator for testing water in the field, Water Res. 6: 1249–1256 (1972).
Wallis, C., and Melnick, J. L., Cationic stabilization-A new property of enteroviruses, Virology 16: 683–700 (1961).
Wallis, C., and Melnick, J. L., Photodynamic inactivation of enteroviruses, J. Bacteriol. 89: 41–46 (1965).
Wallis, C., and Melnick, J. L., Virus aggregation as the cause of the non-neutralizable persistent fraction, J. Virol. 1: 478–488 (1967).
Ward, R., Melnick, J. L., and Horstmann, D. M., Poliomyelitis virus in fly-contaminated food collected at an epidemic, Science 101: 491–493 (1945).
Weiss, L. M., Liu, X.-F., Chang, K. L., and Billingham, M. E., Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues, J. Clin. Invest. 90: 156–159 (1992).
Wenner, H. A., The ECHO viruses, Ann. N.Y. Acad. Sci. 101: 398–412 (1962).
Wenner, H. A., Outline of laboratory procedures for the diagnosis of enterovirus infections, in: Diagnostic Procedures for Viral and Rickettsial Diseases, 3rd ed. (E. H. Lenette and N. J. Schmidt, Eds.), pp. 243–258, American Public Health Association, Washington, 1964.
Wenner, H. A., Virus diseases associated with cutaneous eruptions, Prog. Med. Virol. 16: 269–336 (1973).
Whittle, H., Hazlett, D., Wood, D., and Bell, C., Immunofluorescence technique for the identification of polioviruses, Lancet 39: 429–430 (1992).
Wickman, I., Studien uber Poliomyelitis acuta: Zugleich ein Beitrag zur Kenntnis der Myelitis acuta (1905). [English translation. Nervous and Mental Disease Monograph Series, No. 16, S. Karger, Berlin, 1913 ].
Wilfert, C. M., Buckley, R. H., Mohanakumar, T., Griffiih, J. E, Katz, S. L., Whisnant, J. K., Eggleston, P. A., Moore, M., Treadwell, E., Oxman, M. N., and Rosen, E S., Persistent and fatal central-nervous-system echovirus infections in patients with agammaglobulinemia, N. Engl. J. Med. 296: 1485–1489 (1977).
Wilson, E M., Miranda, Q. R., Chason, J. L., and Lerner, A. M., Residual pathologic changes following murine coxsackie A and B myocarditis, Am. J. Pathol. 55: 253–265 (1979).
Wilson, T., Papahadjopoulos, D., and Taber, R., Biological properties of poliovirus encapsulated in lipid vesicles: Antibody resistance and infectivity in virus-resistant cells, Proc. Natl. Acad. Sci. USA 74: 3471–3475 (1977).
Wimmer, E., Hellen, C. U. T., and Cao, X., Genetics of poliovirus, Annu. Rev. Genet. 27: 353–435 (1993).
Wong, C. Y, Woodruff, J. J., and Woodruff, J. F., Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. II. Characterization of effector cells and demonstration of cytotoxicity against viral-infected myofibers, J. Immunol. 118: 165–169 (1977).
Woodruff, J. E, Viral myocarditis. A review, Am. J. Pathol. 101: 427–478 (1980).
Woodruff, J. E, and Woodruff, J. J., Modification of severe coxsackievirus B3 infection in marasmic mice by transfer of immune lymphoid cells, Proc. Natl. Acad. Sci. USA 68: 2108–2111 (1971).
World Health Organization, WHO Weekly Epidemiological Record 1960–1979.
World Health Organization, WHO Weekly Epidemiological Record and Quarterly and Annual Reports on Virus Isolations 1963–1985.
World Health Organization, Poliomyelitis surveillance, Week. Epidemiol. Rec. 53: 304 (1978).
World Health Organization, Poliomyelitis in 1977, Week. Epidemiol. Rec. 53: 321–327 (1978)
World Health Organization, Poliomyelitis in 1978, Week. Epidemiol. Rec. 54: 361–368 (1979).
World Health Organization, Poliomyelitis in 1979, Parts 1 and 2, Week. Epidemiol. Rec. 55: 361–366, 369–376 (1980).
World Health Organization, Expanded Programme on Immunization (Epi): Poliomyelitis prevalence surveys, Tamil Nadu, India, 1979, Week. Epidemiol. Rec. 56: 131–132 (1981).
World Health Organization, Poliomyelitis in 1980, Parts 1 and 2, Week. Epidemiol. Rec. 56:329–332, 337–341 (1981):
World Health Organization, Poliomyelitis in 1981, Week. Epidemiol. Rec. 57: 305–310 (1982).
World Health Organization, Expanded Programme on Immunization, Bull. WHO 61: 611–615 (1983).
World Health Organization, Poliomyelitis in 1982, Week. Epidemiol. Rec. 58: 385–390 (1983).
World Health Organization (Melnick, J. L., Mordhorst, C. H., and Bektimirov, T.), Virus Disease Surveillance: New Lbm antiserum pools available for typing enteroviruses, Week. Epidemiol. Rec. 59: 345 (1984).
World Health Organization, Expanded Programme on Immunization: Global status report, Week. Epidemiol. Rec. 60: 261–263 (1985).
World Health Organization, Poliomyelitis in 1983, Week. Epidemiol. Rec. 60: 173–179 (1985).
World Health Organization, Status Report: The Global Eradication of Poliomyelitis, May 1993, pp. 1–11, World Health Organization, Geneva, Switzerland, 1993.
World Health Organization Committee ON Poliomyelitis, The relation between acute persisting spinal paralysis and poliomyelitis vaccine (oral): Results of a WHO enquiry, Bull. WHO 53: 319–331 (1976).
World Health Organization Consultative Group, The relation between acute persisting spinal paralysis and poliomyelitis vaccine-results of a ten-year enquiry, Bull. WHO 60: 231–242 (1982).
World Health Organization Scientific Group, Human viruses in water, wastewater, and soil, WHO Tech. Rep. Ser. 639 (1979).
Wreghitt, T. G., Gandy, G. M., King, A., and Sutehall, G., Fatal neonatal echo 7 virus infection, Lancet 2: 465 (1984).
Wright, P. E, Hatch, M. H., Kasselberg, A. G., Lowry, S. P., Wadlington, W. B., and Karzon, D. T., Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia, J. Pediatr. 91: 408–412 (1977).
Wright, P. E, Kim-Farley, R. J., DE Quadros, C. A., Robertson, S. E., Scott, R. M., Ward, N. A., and Henderson, R. H., Strategies for the global eradication of poliomyelitis by the year 2000, N. Engl. J. Med. 325: 1774–1779 (1991).
Wyatt, H. B., Hypothesis: Poliomyelitis in hypogammaglobulinemics, J. Infect. Dis. 128: 802–806 (1973).
Wychowski, C., Van Der Werf, S., Siffert, O., Crainic, R., Bruneau, P., and Girard, M., A poliovirus type 1 neutralization epitope is located within amino acid residues 94 to 104 of viral capsid polypeptide VP1, EMBO J. 2: 2019–2024 (1983).
Yamadera, S., Yamashita, K., Kato, N., Akatsuka, M., Miyamura, K., and Yamazaki, S., Herpangina surveillance in Japan, 1982–1989, Jpn. J. Med. Sci. Biol. 44: 29–39 (1991).
Yamashita, K., Miyamura, K., Yamadera, S., Kato, N., Akatsuka, M., Inouye, S., and Yamazaki, S., Enteroviral aseptic meningitis in Japan, 1981–1991, Jpn. J. Med. Sci. Biol. 45: 151–161 (1992).
Yin-Murphy, M., Viruses of acute haemorrhagic conjunctivitis, Lancet 1: 545–546 (1973).
Yin-Murphy, M., Acute hemorrhagic conjunctivitis, Prog. Med. Virol. 29: 23–44 (1984).
Yin-Murphy, M., and Lim, K. H., Picomavirus epidemic conjunctivitis in Singapore, Lancet 2: 857–858 (1972).
Yin-Murphy, M., Phoon, M. C., and Baharudi-Ishak, Echovirus type 11 infection in Singapore, Singapore Med. J. 25: 38–42 (1984).
Yin-Murphy, M., Wong, H. B., and Goh, K. T., Review of the poliomyelitis immunization campaign and syndromes associated with poliovirus in Singapore, J. Singapore Paed. Soc. 29 (34): 99–107 (1987).
Yodfat, Y., and Nishmi, M., Epidemiologic and clinical observations in six outbreaks of viral disease in a kibbutz, 1968–1971, Am. J. Epidemiol. 97: 415–423 (1973).
Yofe, J., Goldblum, N., Eylan, E., and Melnick, J. L., An outbreak of poliomyelitis in Israel in 1961 and the use of attenuated type 1 vaccine in its control, Am. J. Hyg. 76: 225–238 (1962).
Yolken, R. H., Bishop, C. A., Townsend, T. R., Bolyard, E. A., Bartlett, J., Santos, G. W., and Saral, R., Infectious gastroenteritis in bone-marrow-transplant recipients, N. Engl. J. Med. 306: 1009–1012 (1982).
Yolken, R. H, and Torsch, V. M., Enzyme-linked immunosor-bent assay for detection and identification of coxsackieviruses A, Infect. Immun. 31: 742–750 (1981).
Yoo, J.-W., Austin, M., Onodera, T., and Notkins, A. L., Virus-induced diabetes mellitus. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis, N. Engl. J. Med. 300: 1173–1179 (1979).
Yorke, J. A., Nathanson, N., Pianigiani, G., and Martin, J., Seasonality and the requirements for perpetuation and eradication of viruses in populations, Am. J. Epidemiol. 109: 102–123 (1979).
Young, N. A., Polioviruses, coxsackieviruses, and echoviruses: Comparison of the genomes by RNA hybridization, J. Virol. 11: 832–839 (1973).
Zheng, Z. M., Zhang, J. H., Zhu, W. P., and He, P. J., Isolation of enterovirus type 71 from the vesicle fluid of an adult patient with hand-foot-mouth disease in China, Virol. Sinica 4: 375–382 (1989).
Ziegler, J. B., and Penny, R., Fatal echo 30 virus infection and amyloidosis in X-linked hypogammaglobulinemia, Clin. Immunol. Immunopathol. 3: 347–352 (1975).
Zoll, G. J., Melchers, W. J. G., Kopecka, H., Jambroes, G., Van Der Poel, H. J. A., and Galama, J. M. D., General primer-mediated polymerase chain reaction for detection of enteroviruses: Application for diagnostic routine and persistent infections, J. Clin. Microbiol. 30: 160–165 (1992).
Suggested Reading
Banatvala, J. E. (Ed.), Viral Infections of the Heart, Edward Arnold, London, Boston, 1993.
Brown, F., and Lewis, B. P. (Eds.), Poliovirus attentuation, Dey. Biol. Stand. 78:1–187 (1993).
Cherry, J. D., Enteroviruses, in: Textbook of Pediatric Infectious Diseases, 3rd ed. (R. D. Feigin and J. D. Cherry, Eds.), pp. 1705–1753, W. B. Saunders, Philadelphia, 1992.
International Symposium on Poliomyelitis Control, Pan American Health Organization, Washington, DC, Rev. Infect. Dis. 6 (Suppl. 2) (1984).
Kapsenberg, J., Picornaviridae: The enteroviruses, in: Laboratory Diagnosis of Infectious Diseases, Vol. 2 (E. H. Lennette, P. Halonen, and E A. Murphy, Eds.), pp. 692–722, Springer-Verlag, New York, 1988.
Melnick, J. L., The picomaviruses, in: Portraits of Viruses. A History of Virology, (E Fenner and A. Gibbs, Eds.), pp. 147–188, S. Karger, Basel, 1988.
Melnick, J. L., Live attenuated poliovaccines, in: Vaccines, 2nd ed. (S. A. Plotkin and E. A. Mortimer, JR., Eds.), pp. 155–204, W. B. Saunders, Philadelphia, 1993.
Melnick, J. L., Poliomyelitis: Eradication in sight, Epidemiol. Infect. 108: 1–18 (1992).
Morens, D. M., Pallansch, M. A., and Moore, M., Polioviruses and other enteroviruses, in: Textbook of Human Virology 2nd ed. (R. B. Belshe, Ed.), pp. 317–497, Mosby Year Book, St. Luis, MO, 1990
Paul, J. R., A History of Poliomyelitis, Yale University Press, New Haven, 1971.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Melnick, J.L. (1997). Poliovirus and Other Enteroviruses. In: Evans, A.S., Kaslow, R.A. (eds) Viral Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0036-4_21
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0036-4_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-44856-0
Online ISBN: 978-1-4899-0036-4
eBook Packages: Springer Book Archive